DY11 |
DPH |
Alameda Health System |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
18543 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.1.2 |
Care Coordinator Assignment |
0 |
0 |
4537 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1726 |
0 |
4935 |
0 |
1 |
0.3497 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.1.5.f |
Screening for Clinical Depression and follow-up |
130 |
0 |
16846 |
0 |
1 |
0.0077 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.1.6.t |
Tobacco Assessment and Counseling |
12903 |
0 |
14480 |
0 |
1 |
0.8911 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
18543 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.2.11 |
REAL data completeness |
24762 |
0 |
24767 |
0 |
1 |
0.9998 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.12.f |
Screening for Clinical Depression and follow-up |
130 |
0 |
16846 |
0 |
1 |
0.0077 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.14.t |
Tobacco Assessment and Counseling |
12903 |
0 |
14480 |
0 |
1 |
0.8911 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.2 |
CG-CAHPS: Provider Rating |
1511 |
0 |
2282 |
0 |
1 |
0.6621 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.2.3.c |
Colorectal Cancer Screening |
5187 |
0 |
9339 |
0 |
1 |
0.5554 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1726 |
0 |
4935 |
0 |
1 |
0.3497 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.5.b |
Controlling Blood Pressure |
4270 |
0 |
5975 |
0 |
1 |
0.7146 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
304 |
0 |
827 |
0 |
1 |
0.3676 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.2.8 |
Prevention Quality Overall Composite #90 |
261 |
0 |
40807 |
0 |
1 |
0.0064 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
3605 |
0 |
12747 |
0 |
1 |
0.2828 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.3.2 |
DHCS All-Cause Readmissions |
122 |
0 |
1055 |
0 |
1 |
0.1156 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.3.3 |
Influenza Immunization |
292 |
0 |
450 |
0 |
1 |
0.6489 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.3.4 |
Post Procedure ED Visits |
179 |
0 |
8145 |
0 |
1 |
0.022 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
2409 |
0 |
23237 |
0 |
1 |
0.1037 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
303 |
0 |
23237 |
0 |
1 |
0.013 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.3.7 |
Tobacco Assessment and Counseling |
6211 |
0 |
7283 |
0 |
1 |
0.8528 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
155 |
0 |
460 |
0 |
1 |
0.337 |
0 |
N/A |
3 |
N/A |
$259,445.97 |
DY11 |
DPH |
Alameda Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
1650 |
0 |
3468 |
0 |
1 |
0.4758 |
0 |
N/A |
3 |
N/A |
$259,445.97 |
DY11 |
DPH |
Alameda Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
4715 |
0 |
9757 |
0 |
1 |
0.4832 |
0 |
N/A |
3 |
N/A |
$259,445.97 |
DY11 |
DPH |
Alameda Health System |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
6513 |
0 |
8647 |
0 |
1 |
0.7532 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
28 |
0 |
222 |
0 |
1 |
0.1261 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.6.1 |
BIRADS to Biopsy |
34 |
0 |
176 |
0 |
1 |
0.1932 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.6.2 |
Breast Cancer Screening |
3488 |
0 |
6109 |
0 |
1 |
0.571 |
0 |
N/A |
3 |
N/A |
$778,337.91 |
DY11 |
DPH |
Alameda Health System |
1.6.3 |
Cervical Cancer Screening |
3127 |
0 |
12240 |
0 |
1 |
0.2555 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.6.4.c |
Colorectal Cancer Screening |
5187 |
0 |
9339 |
0 |
1 |
0.5554 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
80 |
0 |
152 |
0 |
1 |
0.5263 |
0 |
N/A |
3 |
N/A |
$778,337.90 |
DY11 |
DPH |
Alameda Health System |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
168 |
0 |
196 |
0 |
1 |
0.8571 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1124 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
72 |
0 |
1124 |
0 |
1 |
0.0641 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.1.5 |
PC-02 Cesarean Section |
56 |
0 |
353 |
0 |
1 |
0.1586 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
633 |
0 |
849 |
0 |
1 |
0.7456 |
0 |
N/A |
3 |
N/A |
$419,625.65 |
DY11 |
DPH |
Alameda Health System |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
538 |
0 |
1063 |
0 |
1 |
0.5061 |
0 |
N/A |
3 |
N/A |
$419,625.65 |
DY11 |
DPH |
Alameda Health System |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
21 |
0 |
106 |
0 |
1 |
0.1981 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.1.8 |
Unexpected Newborn Complications (UNC) |
88 |
0 |
883 |
0 |
1 |
0.0997 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.1.9 |
OB Hemorrhage Safety Bundle |
8 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.2.1 |
DHCS All-Cause Readmissions |
132 |
0 |
1362 |
0 |
1 |
0.0969 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
4090 |
0 |
10000 |
0 |
1 |
0.409 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
696 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
2358 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
1936 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.3.1 |
Care Coordinator Assignment |
300 |
0 |
2493 |
0 |
1 |
0.1203 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
354 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.3.3 |
Prevention Quality Overall Composite #90 |
208 |
0 |
2493 |
0 |
1 |
0.0834 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
2493 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.31 |
DY11 |
DPH |
Alameda Health System |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$839,251.30 |
DY11 |
DPH |
Alameda Health System |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
83 |
0 |
138 |
0 |
1 |
0.6014 |
0 |
N/A |
3 |
N/A |
$965,139.00 |
DY11 |
DPH |
Alameda Health System |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
191 |
0 |
1267 |
0 |
1 |
0.1507 |
0 |
N/A |
3 |
N/A |
$965,139.00 |
DY11 |
DPH |
Alameda Health System |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
606 |
0 |
18146 |
0 |
1 |
0.0334 |
0 |
N/A |
3 |
N/A |
$965,139.00 |
DY11 |
DPH |
Alameda Health System |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
56 |
0 |
118 |
0 |
1 |
0.4746 |
0 |
N/A |
3 |
N/A |
$965,139.00 |
DY11 |
DPH |
Alameda Health System |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
5700 |
0 |
10000 |
0 |
1 |
0.57 |
0 |
N/A |
3 |
N/A |
$965,139.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
16068 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.2 |
Care Coordinator Assignment |
3891 |
0 |
5866 |
0 |
1 |
0.6633 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2042 |
0 |
5866 |
0 |
1 |
0.3481 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
79 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
0 |
16068 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
272 |
0 |
377 |
0 |
1 |
0.7215 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
16068 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.76 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.11 |
REAL data completeness |
3754 |
0 |
24041 |
0 |
1 |
0.1561 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
0 |
16068 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
272 |
0 |
377 |
0 |
1 |
0.7215 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
1267 |
0 |
1799 |
0 |
1 |
0.7043 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
3441 |
0 |
8430 |
0 |
1 |
0.4082 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2042 |
0 |
5866 |
0 |
1 |
0.3481 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.5.b |
Controlling Blood Pressure |
4068 |
0 |
6715 |
0 |
1 |
0.6058 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
247 |
0 |
323 |
0 |
1 |
0.7647 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
714 |
0 |
34991 |
0 |
1 |
0.0204 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.76 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
319 |
0 |
2172 |
0 |
1 |
0.1469 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.3 |
Influenza Immunization |
0 |
0 |
8084 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.4 |
Post Procedure ED Visits |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
0 |
0 |
8756 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.7.1 |
BMI Screening and Follow-up |
114 |
0 |
377 |
0 |
1 |
0.3024 |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
0 |
8 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,242,230.77 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
108 |
0 |
341 |
0 |
1 |
0.3167 |
0 |
N/A |
3 |
N/A |
$414,076.92 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
151 |
0 |
341 |
0 |
1 |
0.4428 |
0 |
N/A |
3 |
N/A |
$414,076.92 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
218 |
0 |
341 |
0 |
1 |
0.6393 |
0 |
N/A |
3 |
N/A |
$414,076.92 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
105 |
0 |
210 |
0 |
1 |
0.5 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
633 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
33 |
0 |
633 |
0 |
1 |
0.0521 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.5 |
PC-02 Cesarean Section |
44 |
0 |
213 |
0 |
1 |
0.2066 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
102 |
0 |
235 |
0 |
1 |
0.434 |
0 |
N/A |
3 |
N/A |
$516,768.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
118 |
0 |
235 |
0 |
1 |
0.5021 |
0 |
N/A |
3 |
N/A |
$516,768.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
16 |
0 |
37 |
0 |
1 |
0.4324 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
11 |
0 |
402 |
0 |
1 |
0.0274 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
6 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
53 |
0 |
351 |
0 |
1 |
0.151 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
49 |
0 |
100 |
0 |
1 |
0.49 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
85 |
0 |
341 |
0 |
1 |
0.2493 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
357 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
4105 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.3.1 |
Care Coordinator Assignment |
None |
1 |
370 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
95 |
0 |
323 |
0 |
1 |
0.2941 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
20 |
0 |
370 |
0 |
1 |
0.0541 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
1966 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.1 |
Adolescent Well-Care Visit |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.2 |
Developmental Screening in the First Three Years of Life |
0 |
0 |
31 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.3 |
Documentation of Current Medications in the Medical Record (0-18 yo) |
0 |
0 |
57 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.5 |
Tobacco Assessment and Counseling (13 yo and older) |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.6 |
Well Child Visits - First 15 months of life |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
2.4.7 |
Well Child Visits - Third, Fourth, Fifth, and Sixth Years of life |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,033,536.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
0 |
163 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,291,920.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
271 |
0 |
662 |
0 |
1 |
0.4094 |
0 |
N/A |
3 |
N/A |
$1,291,920.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,291,920.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
0 |
323 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,291,920.00 |
DY11 |
DPH |
Arrowhead Regional Medical Center |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
6590 |
0 |
10000 |
0 |
1 |
0.659 |
0 |
N/A |
3 |
N/A |
$1,291,920.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
5386 |
0 |
44679 |
0 |
1 |
0.1205 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.2 |
Care Coordinator Assignment |
9361 |
0 |
9465 |
0 |
1 |
0.989 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2379 |
0 |
7594 |
0 |
1 |
0.3133 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
724 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
11337 |
0 |
30835 |
0 |
1 |
0.3677 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
33427 |
0 |
40703 |
0 |
1 |
0.8212 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
5386 |
0 |
44679 |
0 |
1 |
0.1205 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.11 |
REAL data completeness |
11991 |
0 |
52604 |
0 |
1 |
0.2279 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
11337 |
0 |
30835 |
0 |
1 |
0.3677 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
33427 |
0 |
40703 |
0 |
1 |
0.8212 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
83 |
0 |
136 |
0 |
1 |
0.6103 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
9841 |
0 |
17312 |
0 |
1 |
0.5684 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2379 |
0 |
7594 |
0 |
1 |
0.3133 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.5.b |
Controlling Blood Pressure |
5995 |
0 |
9764 |
0 |
1 |
0.614 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
1644 |
0 |
1969 |
0 |
1 |
0.8349 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
569 |
0 |
60048 |
0 |
1 |
0.0095 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
20366 |
0 |
20366 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
179 |
0 |
1941 |
0 |
1 |
0.0922 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.3 |
Influenza Immunization |
15472 |
0 |
25380 |
0 |
1 |
0.6096 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.4 |
Post Procedure ED Visits |
233 |
0 |
16253 |
0 |
1 |
0.0143 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
29943 |
0 |
49805 |
0 |
1 |
0.6012 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
31 |
0 |
52155 |
0 |
1 |
0.0006 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
22399 |
0 |
26852 |
0 |
1 |
0.8342 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.6.1 |
BIRADS to Biopsy |
50 |
0 |
82 |
0 |
1 |
0.6098 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.6.2 |
Breast Cancer Screening |
8065 |
0 |
11817 |
0 |
1 |
0.6825 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.6.3 |
Cervical Cancer Screening |
13024 |
0 |
25289 |
0 |
1 |
0.515 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.6.4.c |
Colorectal Cancer Screening |
9841 |
0 |
17312 |
0 |
1 |
0.5684 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
121 |
0 |
249 |
0 |
1 |
0.4859 |
0 |
N/A |
3 |
N/A |
$1,008,018.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
723 |
0 |
1343 |
0 |
1 |
0.5383 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1542 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
53 |
0 |
1542 |
0 |
1 |
0.0344 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.5 |
PC-02 Cesarean Section |
109 |
0 |
462 |
0 |
1 |
0.2359 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1041 |
0 |
1114 |
0 |
1 |
0.9345 |
0 |
N/A |
3 |
N/A |
$376,327.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
1172 |
0 |
1483 |
0 |
1 |
0.7903 |
0 |
N/A |
3 |
N/A |
$376,327.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
20 |
0 |
158 |
0 |
1 |
0.1266 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
51 |
0 |
1150 |
0 |
1 |
0.0443 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
15 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
187 |
0 |
2112 |
0 |
1 |
0.0885 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
296 |
0 |
673 |
0 |
1 |
0.4398 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
3515 |
0 |
3585 |
0 |
1 |
0.9805 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
5288 |
0 |
5408 |
0 |
1 |
0.9778 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
121 |
0 |
4643 |
0 |
1 |
0.0261 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.3.1 |
Care Coordinator Assignment |
6236 |
0 |
6304 |
0 |
1 |
0.9892 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
1279 |
0 |
1317 |
0 |
1 |
0.9711 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
403 |
0 |
13896 |
0 |
1 |
0.029 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
95 |
0 |
1627 |
0 |
1 |
0.0584 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.1 |
Adolescent Well-Care Visit |
41 |
0 |
52 |
0 |
1 |
0.7885 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.2 |
Developmental Screening in the First Three Years of Life |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.3 |
Documentation of Current Medications in the Medical Record (0-18 yo) |
25 |
0 |
228 |
0 |
1 |
0.1096 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.4 |
Screening for Clinical Depression and follow-up |
22 |
0 |
33 |
0 |
1 |
0.6667 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.5 |
Tobacco Assessment and Counseling (13 yo and older) |
33 |
0 |
36 |
0 |
1 |
0.9167 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.6 |
Well Child Visits - First 15 months of life |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.4.7 |
Well Child Visits - Third, Fourth, Fifth, and Sixth Years of life |
21 |
0 |
None |
4 |
1 |
None |
4 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
393 |
0 |
4743 |
0 |
1 |
0.0829 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
970 |
0 |
3123 |
0 |
1 |
0.3106 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
996 |
0 |
2250 |
0 |
1 |
0.4427 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.6.4 |
Screening for Clinical Depression and follow-up |
1017 |
0 |
2688 |
0 |
1 |
0.3783 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
4176 |
0 |
5051 |
0 |
1 |
0.8268 |
0 |
N/A |
3 |
N/A |
$752,654.00 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
598 |
0 |
4346 |
0 |
1 |
0.1376 |
0 |
N/A |
3 |
N/A |
$1,411,226.25 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
112 |
0 |
197 |
0 |
1 |
0.5685 |
0 |
N/A |
3 |
N/A |
$1,411,226.25 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
2364 |
0 |
2802 |
0 |
1 |
0.8437 |
0 |
N/A |
3 |
N/A |
$1,411,226.25 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
330 |
0 |
7619 |
0 |
1 |
0.0433 |
0 |
N/A |
3 |
N/A |
$470,408.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
433 |
0 |
7619 |
0 |
1 |
0.0568 |
0 |
N/A |
3 |
N/A |
$470,408.75 |
DY11 |
DPH |
Contra Costa Regional Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
801 |
0 |
7619 |
0 |
1 |
0.1051 |
0 |
N/A |
3 |
N/A |
$470,408.75 |
DY11 |
DPH |
Kern Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
2295 |
0 |
8104 |
0 |
1 |
0.2832 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.1.2 |
Care Coordinator Assignment |
83 |
0 |
2071 |
0 |
1 |
0.0401 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
604 |
0 |
1925 |
0 |
1 |
0.3138 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
50 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
0 |
6798 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
2584 |
0 |
6917 |
0 |
1 |
0.3736 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
2295 |
0 |
8104 |
0 |
1 |
0.2832 |
0 |
N/A |
3 |
N/A |
$914,630.76 |
DY11 |
DPH |
Kern Medical Center |
1.2.11 |
REAL data completeness |
0 |
0 |
6571 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
0 |
6798 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
2584 |
0 |
6917 |
0 |
1 |
0.3736 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
65 |
0 |
97 |
0 |
1 |
0.6701 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
967 |
0 |
3046 |
0 |
1 |
0.3175 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
604 |
0 |
1925 |
0 |
1 |
0.3138 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.5.b |
Controlling Blood Pressure |
1013 |
0 |
2210 |
0 |
1 |
0.4584 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
310 |
0 |
523 |
0 |
1 |
0.5927 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
157 |
0 |
8714 |
0 |
1 |
0.018 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
0 |
0 |
7124 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.76 |
DY11 |
DPH |
Kern Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
None |
1 |
54 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.3 |
Influenza Immunization |
1374 |
0 |
3802 |
0 |
1 |
0.3614 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.4 |
Post Procedure ED Visits |
896 |
0 |
11741 |
0 |
1 |
0.0763 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
0 |
0 |
78014 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
78014 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
1790 |
0 |
3910 |
0 |
1 |
0.4578 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
55 |
0 |
79 |
0 |
1 |
0.6962 |
0 |
N/A |
3 |
N/A |
$304,876.92 |
DY11 |
DPH |
Kern Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
412 |
0 |
432 |
0 |
1 |
0.9537 |
0 |
N/A |
3 |
N/A |
$304,876.92 |
DY11 |
DPH |
Kern Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
127 |
0 |
718 |
0 |
1 |
0.1769 |
0 |
N/A |
3 |
N/A |
$304,876.92 |
DY11 |
DPH |
Kern Medical Center |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
411 |
0 |
672 |
0 |
1 |
0.6116 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
15 |
0 |
41 |
0 |
1 |
0.3659 |
0 |
N/A |
3 |
N/A |
$914,630.77 |
DY11 |
DPH |
Kern Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$827,144.34 |
DY11 |
DPH |
Kern Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
292 |
0 |
793 |
0 |
1 |
0.3682 |
0 |
N/A |
3 |
N/A |
$827,144.34 |
DY11 |
DPH |
Kern Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1054 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
163 |
0 |
1054 |
0 |
1 |
0.1546 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.1.5 |
PC-02 Cesarean Section |
45 |
0 |
227 |
0 |
1 |
0.1982 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
209 |
0 |
488 |
0 |
1 |
0.4283 |
0 |
N/A |
3 |
N/A |
$413,572.18 |
DY11 |
DPH |
Kern Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
166 |
0 |
595 |
0 |
1 |
0.279 |
0 |
N/A |
3 |
N/A |
$413,572.18 |
DY11 |
DPH |
Kern Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
40 |
0 |
92 |
0 |
1 |
0.4348 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
50 |
0 |
800 |
0 |
1 |
0.0625 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
5 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
190 |
0 |
813 |
0 |
1 |
0.2337 |
0 |
N/A |
3 |
N/A |
$827,144.34 |
DY11 |
DPH |
Kern Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
4727 |
0 |
10000 |
0 |
1 |
0.4727 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
908 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
9689 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
7156 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.3.1 |
Care Coordinator Assignment |
129 |
0 |
1085 |
0 |
1 |
0.1189 |
0 |
N/A |
3 |
N/A |
$827,144.34 |
DY11 |
DPH |
Kern Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
120 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
48 |
0 |
1085 |
0 |
1 |
0.0442 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
208 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.5.1 |
Alcohol and Drug Misuse (SBIRT) |
99 |
0 |
377 |
0 |
1 |
0.2626 |
0 |
N/A |
3 |
N/A |
$827,144.34 |
DY11 |
DPH |
Kern Medical Center |
2.5.2 |
Controlling Blood Pressure |
43 |
0 |
91 |
0 |
1 |
0.4725 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.5.3 |
Prevention Quality Overall Composite #90 |
0 |
0 |
206 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.5.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
368 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
2.5.5 |
Tobacco Assessment and Counseling |
215 |
0 |
371 |
0 |
1 |
0.5795 |
0 |
N/A |
3 |
N/A |
$827,144.35 |
DY11 |
DPH |
Kern Medical Center |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
69 |
0 |
378 |
0 |
1 |
0.1825 |
0 |
N/A |
3 |
N/A |
$1,189,020.00 |
DY11 |
DPH |
Kern Medical Center |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
96 |
0 |
134 |
0 |
1 |
0.7164 |
0 |
N/A |
3 |
N/A |
$1,189,020.00 |
DY11 |
DPH |
Kern Medical Center |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
315 |
0 |
442 |
0 |
1 |
0.7127 |
0 |
N/A |
3 |
N/A |
$1,189,020.00 |
DY11 |
DPH |
Kern Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
None |
1 |
436 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$396,340.00 |
DY11 |
DPH |
Kern Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
51 |
0 |
436 |
0 |
1 |
0.117 |
0 |
N/A |
3 |
N/A |
$396,340.00 |
DY11 |
DPH |
Kern Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
224 |
0 |
436 |
0 |
1 |
0.5138 |
0 |
N/A |
3 |
N/A |
$396,340.00 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
12 |
0 |
378 |
0 |
1 |
0.0317 |
0 |
N/A |
3 |
N/A |
$4,934,752.95 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.2 |
Care Coordinator Assignment |
0 |
0 |
377 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,934,752.95 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
9780 |
0 |
33337 |
0 |
1 |
0.2934 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.5.f |
Screening for Clinical Depression and follow-up |
318 |
0 |
377 |
0 |
1 |
0.8435 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.1.6.t |
Tobacco Assessment and Counseling |
92777 |
0 |
131470 |
0 |
1 |
0.7057 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
12 |
0 |
378 |
0 |
1 |
0.0317 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.11 |
REAL data completeness |
0 |
0 |
125619 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.12.f |
Screening for Clinical Depression and follow-up |
318 |
0 |
377 |
0 |
1 |
0.8435 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.14.t |
Tobacco Assessment and Counseling |
92777 |
0 |
131470 |
0 |
1 |
0.7057 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.2 |
CG-CAHPS: Provider Rating |
2571 |
0 |
4221 |
0 |
1 |
0.6091 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.3.c |
Colorectal Cancer Screening |
39402 |
0 |
63323 |
0 |
1 |
0.6222 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
9780 |
0 |
33337 |
0 |
1 |
0.2934 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.5.b |
Controlling Blood Pressure |
28660 |
0 |
44832 |
0 |
1 |
0.6393 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
5683 |
0 |
7006 |
0 |
1 |
0.8112 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.2.8 |
Prevention Quality Overall Composite #90 |
8188 |
0 |
262845 |
0 |
1 |
0.0312 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
187179 |
0 |
213642 |
0 |
1 |
0.8761 |
0 |
N/A |
3 |
N/A |
$4,934,752.95 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.2 |
DHCS All-Cause Readmissions |
591 |
0 |
4517 |
0 |
1 |
0.1308 |
0 |
N/A |
3 |
N/A |
$4,934,752.95 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.3 |
Influenza Immunization |
19798 |
0 |
54491 |
0 |
1 |
0.3633 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.4 |
Post Procedure ED Visits |
544 |
0 |
31419 |
0 |
1 |
0.0173 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
116771 |
0 |
148142 |
0 |
1 |
0.7882 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
36993 |
0 |
160780 |
0 |
1 |
0.2301 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.3.7 |
Tobacco Assessment and Counseling |
61957 |
0 |
79710 |
0 |
1 |
0.7773 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
12309 |
0 |
21963 |
0 |
1 |
0.5604 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
27253 |
0 |
29004 |
0 |
1 |
0.9396 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
76105 |
0 |
79933 |
0 |
1 |
0.9521 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
50995 |
0 |
61803 |
0 |
1 |
0.8251 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
1225 |
0 |
2008 |
0 |
1 |
0.6101 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.6.1 |
BIRADS to Biopsy |
273 |
0 |
621 |
0 |
1 |
0.4396 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.6.2 |
Breast Cancer Screening |
30237 |
0 |
50136 |
0 |
1 |
0.6031 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.6.3 |
Cervical Cancer Screening |
35019 |
0 |
102269 |
0 |
1 |
0.3424 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.6.4.c |
Colorectal Cancer Screening |
39402 |
0 |
63323 |
0 |
1 |
0.6222 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
374 |
0 |
1188 |
0 |
1 |
0.3148 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.7.1 |
BMI Screening and Follow-up |
36813 |
0 |
113301 |
0 |
1 |
0.3249 |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
21 |
0 |
40 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$4,934,752.94 |
DY11 |
DPH |
Los Angeles County Health System |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
656 |
0 |
14464 |
0 |
1 |
0.0454 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
1112 |
0 |
14464 |
0 |
1 |
0.0769 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
6590 |
0 |
14464 |
0 |
1 |
0.4556 |
0 |
N/A |
3 |
N/A |
$1,644,917.65 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$4,628,457.94 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
463 |
0 |
1115 |
0 |
1 |
0.4152 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1777 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
140 |
0 |
1777 |
0 |
1 |
0.0788 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.5 |
PC-02 Cesarean Section |
156 |
0 |
630 |
0 |
1 |
0.2476 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
815 |
0 |
2242 |
0 |
1 |
0.3635 |
0 |
N/A |
3 |
N/A |
$2,314,228.97 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1103 |
0 |
2242 |
0 |
1 |
0.492 |
0 |
N/A |
3 |
N/A |
$2,314,228.97 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
54 |
0 |
124 |
0 |
1 |
0.4355 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.8 |
Unexpected Newborn Complications (UNC) |
126 |
0 |
1074 |
0 |
1 |
0.1173 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.1.9 |
OB Hemorrhage Safety Bundle |
28 |
0 |
48 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.2.1 |
DHCS All-Cause Readmissions |
672 |
0 |
5261 |
0 |
1 |
0.1277 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
4702 |
0 |
8389 |
0 |
1 |
0.5605 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.2.3 |
Medication Reconciliation 30 days |
109 |
0 |
377 |
0 |
1 |
0.2891 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
242 |
0 |
413 |
0 |
1 |
0.586 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
370 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
377 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,628,457.94 |
DY11 |
DPH |
Los Angeles County Health System |
2.3.2 |
Medication Reconciliation 30 days |
96 |
0 |
377 |
0 |
1 |
0.2546 |
0 |
N/A |
3 |
N/A |
$4,628,457.94 |
DY11 |
DPH |
Los Angeles County Health System |
2.3.3 |
Prevention Quality Overall Composite #90 |
8115 |
0 |
67847 |
0 |
1 |
0.1196 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
370 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.5.1 |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
116 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.5.2 |
Controlling Blood Pressure |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.5.3 |
Prevention Quality Overall Composite #90 |
11 |
0 |
144 |
0 |
1 |
0.0764 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.5.4 |
Screening for Clinical Depression and follow-up |
66 |
0 |
93 |
0 |
1 |
0.7097 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.5.5 |
Tobacco Assessment and Counseling |
74 |
0 |
126 |
0 |
1 |
0.5873 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.1 |
Advance Care Plan |
348 |
0 |
357 |
0 |
1 |
0.9748 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
18 |
0 |
50 |
0 |
1 |
0.36 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
62 |
0 |
323 |
0 |
1 |
0.192 |
0 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
None |
1 |
32 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$4,628,457.93 |
DY11 |
DPH |
Los Angeles County Health System |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
328 |
0 |
957 |
0 |
1 |
0.3427 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
44 |
0 |
107 |
0 |
1 |
0.4112 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
70638 |
0 |
365348 |
0 |
1 |
0.1933 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
101 |
0 |
349 |
0 |
1 |
0.2894 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
7778 |
0 |
10000 |
0 |
1 |
0.7778 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.3.1 |
Adherence to Medications |
92 |
0 |
102 |
0 |
1 |
0.902 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.3.2 |
Documentation of Current Medications in the Medical Record |
177 |
0 |
384 |
0 |
1 |
0.4609 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Los Angeles County Health System |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
60 |
0 |
102 |
0 |
1 |
0.5882 |
0 |
N/A |
3 |
N/A |
$4,194,540.00 |
DY11 |
DPH |
Natividad Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
3297 |
0 |
6521 |
0 |
1 |
0.5056 |
0 |
N/A |
3 |
N/A |
$441,661.12 |
DY11 |
DPH |
Natividad Medical Center |
1.1.2 |
Care Coordinator Assignment |
0 |
0 |
1515 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
384 |
0 |
907 |
0 |
1 |
0.4234 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
167 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
2318 |
0 |
4073 |
0 |
1 |
0.5691 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
5482 |
0 |
5796 |
0 |
1 |
0.9458 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
3297 |
0 |
6521 |
0 |
1 |
0.5056 |
0 |
N/A |
3 |
N/A |
$441,661.12 |
DY11 |
DPH |
Natividad Medical Center |
1.2.11 |
REAL data completeness |
8641 |
0 |
9628 |
0 |
1 |
0.8975 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
2318 |
0 |
4073 |
0 |
1 |
0.5691 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
5482 |
0 |
5796 |
0 |
1 |
0.9458 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
70 |
0 |
100 |
0 |
1 |
0.7 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
834 |
0 |
1579 |
0 |
1 |
0.5282 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
384 |
0 |
907 |
0 |
1 |
0.4234 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.5.b |
Controlling Blood Pressure |
970 |
0 |
1470 |
0 |
1 |
0.6599 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
180 |
0 |
204 |
0 |
1 |
0.8824 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
72 |
0 |
8543 |
0 |
1 |
0.0084 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
473 |
0 |
493 |
0 |
1 |
0.9594 |
0 |
N/A |
3 |
N/A |
$441,661.12 |
DY11 |
DPH |
Natividad Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
37 |
0 |
251 |
0 |
1 |
0.1474 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.3 |
Influenza Immunization |
515 |
0 |
1128 |
0 |
1 |
0.4566 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.4 |
Post Procedure ED Visits |
165 |
0 |
6057 |
0 |
1 |
0.0272 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
400 |
0 |
1629 |
0 |
1 |
0.2455 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
1938 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
1482 |
0 |
1549 |
0 |
1 |
0.9567 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.5.1.b |
Controlling Blood Pressure |
970 |
0 |
1470 |
0 |
1 |
0.6599 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
180 |
0 |
204 |
0 |
1 |
0.8824 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
1931 |
0 |
3945 |
0 |
1 |
0.4895 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
1.5.4.t |
Tobacco Assessment and Counseling |
5482 |
0 |
5796 |
0 |
1 |
0.9458 |
0 |
N/A |
3 |
N/A |
$441,661.11 |
DY11 |
DPH |
Natividad Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$414,777.40 |
DY11 |
DPH |
Natividad Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
121 |
0 |
302 |
0 |
1 |
0.4007 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
382 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
25 |
0 |
382 |
0 |
1 |
0.0654 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.5 |
PC-02 Cesarean Section |
24 |
0 |
108 |
0 |
1 |
0.2222 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
93 |
0 |
393 |
0 |
1 |
0.2366 |
0 |
N/A |
3 |
N/A |
$207,388.70 |
DY11 |
DPH |
Natividad Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
219 |
0 |
393 |
0 |
1 |
0.5573 |
0 |
N/A |
3 |
N/A |
$207,388.70 |
DY11 |
DPH |
Natividad Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
None |
1 |
57 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
12 |
0 |
332 |
0 |
1 |
0.0361 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
8 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
49 |
0 |
377 |
0 |
1 |
0.13 |
0 |
N/A |
3 |
N/A |
$414,777.40 |
DY11 |
DPH |
Natividad Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
3900 |
0 |
10000 |
0 |
1 |
0.39 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
240 |
0 |
359 |
0 |
1 |
0.6685 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
430 |
0 |
481 |
0 |
1 |
0.894 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
414 |
0 |
474 |
0 |
1 |
0.8734 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
254 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
46 |
0 |
64 |
0 |
1 |
0.7188 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
24 |
0 |
333 |
0 |
1 |
0.0721 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
84 |
0 |
95 |
0 |
1 |
0.8842 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
343 |
0 |
554 |
0 |
1 |
0.6191 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
118 |
0 |
381 |
0 |
1 |
0.3097 |
0 |
N/A |
3 |
N/A |
$414,777.40 |
DY11 |
DPH |
Natividad Medical Center |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
0 |
381 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.6.4 |
Screening for Clinical Depression and follow-up |
128 |
0 |
205 |
0 |
1 |
0.6244 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
140 |
0 |
147 |
0 |
1 |
0.9524 |
0 |
N/A |
3 |
N/A |
$414,777.39 |
DY11 |
DPH |
Natividad Medical Center |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
17 |
0 |
127 |
0 |
1 |
0.1339 |
0 |
N/A |
3 |
N/A |
$476,994.00 |
DY11 |
DPH |
Natividad Medical Center |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$476,994.00 |
DY11 |
DPH |
Natividad Medical Center |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
51 |
0 |
76 |
0 |
1 |
0.6711 |
0 |
N/A |
3 |
N/A |
$476,994.00 |
DY11 |
DPH |
Natividad Medical Center |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
288 |
0 |
288 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$476,994.00 |
DY11 |
DPH |
Natividad Medical Center |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$476,994.00 |
DY11 |
DPH |
Riverside University Health System |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
21421 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.1.2 |
Care Coordinator Assignment |
None |
1 |
386 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2096 |
0 |
4116 |
0 |
1 |
0.5092 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
54 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.1.5.f |
Screening for Clinical Depression and follow-up |
27 |
0 |
391 |
0 |
1 |
0.0691 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.1.6.t |
Tobacco Assessment and Counseling |
6368 |
0 |
15530 |
0 |
1 |
0.41 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
21421 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.2.11 |
REAL data completeness |
0 |
0 |
35298 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.12.f |
Screening for Clinical Depression and follow-up |
27 |
0 |
391 |
0 |
1 |
0.0691 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.14.t |
Tobacco Assessment and Counseling |
6368 |
0 |
15530 |
0 |
1 |
0.41 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.2 |
CG-CAHPS: Provider Rating |
62 |
0 |
100 |
0 |
1 |
0.62 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.2.3.c |
Colorectal Cancer Screening |
590 |
0 |
8736 |
0 |
1 |
0.0675 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2096 |
0 |
4116 |
0 |
1 |
0.5092 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.5.b |
Controlling Blood Pressure |
172 |
0 |
371 |
0 |
1 |
0.4636 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
289 |
0 |
457 |
0 |
1 |
0.6324 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.2.8 |
Prevention Quality Overall Composite #90 |
378 |
0 |
57412 |
0 |
1 |
0.0066 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
18 |
0 |
94 |
0 |
1 |
0.1915 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.3.2 |
DHCS All-Cause Readmissions |
42 |
0 |
239 |
0 |
1 |
0.1757 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.3.3 |
Influenza Immunization |
0 |
0 |
1960 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.3.4 |
Post Procedure ED Visits |
177 |
0 |
9554 |
0 |
1 |
0.0185 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
170 |
0 |
398 |
0 |
1 |
0.4271 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
5149 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.3.7 |
Tobacco Assessment and Counseling |
0 |
0 |
1406 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.5.1.b |
Controlling Blood Pressure |
172 |
0 |
371 |
0 |
1 |
0.4636 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
289 |
0 |
457 |
0 |
1 |
0.6324 |
0 |
N/A |
3 |
N/A |
$927,208.34 |
DY11 |
DPH |
Riverside University Health System |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
225 |
0 |
407 |
0 |
1 |
0.5528 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
1.5.4.t |
Tobacco Assessment and Counseling |
6368 |
0 |
15530 |
0 |
1 |
0.41 |
0 |
N/A |
3 |
N/A |
$927,208.33 |
DY11 |
DPH |
Riverside University Health System |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
245 |
0 |
403 |
0 |
1 |
0.6079 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
531 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
86 |
0 |
531 |
0 |
1 |
0.162 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.1.5 |
PC-02 Cesarean Section |
28 |
0 |
145 |
0 |
1 |
0.1931 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
32 |
0 |
76 |
0 |
1 |
0.4211 |
0 |
N/A |
3 |
N/A |
$435,384.79 |
DY11 |
DPH |
Riverside University Health System |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
42 |
0 |
76 |
0 |
1 |
0.5526 |
0 |
N/A |
3 |
N/A |
$435,384.79 |
DY11 |
DPH |
Riverside University Health System |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
16 |
0 |
36 |
0 |
1 |
0.4444 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.1.8 |
Unexpected Newborn Complications (UNC) |
28 |
0 |
404 |
0 |
1 |
0.0693 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.1.9 |
OB Hemorrhage Safety Bundle |
14 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.2.1 |
DHCS All-Cause Readmissions |
38 |
0 |
559 |
0 |
1 |
0.068 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
4713 |
0 |
10000 |
0 |
1 |
0.4713 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.2.3 |
Medication Reconciliation 30 days |
33 |
0 |
258 |
0 |
1 |
0.1279 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
177 |
0 |
363 |
0 |
1 |
0.4876 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
37 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
200 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.3.2 |
Medication Reconciliation 30 days |
None |
1 |
36 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.3.3 |
Prevention Quality Overall Composite #90 |
38 |
0 |
849 |
0 |
1 |
0.0448 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
45 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
420 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
0 |
52 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$870,769.56 |
DY11 |
DPH |
Riverside University Health System |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
None |
1 |
52 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.6.4 |
Screening for Clinical Depression and follow-up |
25 |
0 |
259 |
0 |
1 |
0.0965 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
105 |
0 |
535 |
0 |
1 |
0.1963 |
0 |
N/A |
3 |
N/A |
$870,769.57 |
DY11 |
DPH |
Riverside University Health System |
3.3.1 |
Adherence to Medications |
0 |
0 |
373 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,668,975.00 |
DY11 |
DPH |
Riverside University Health System |
3.3.2 |
Documentation of Current Medications in the Medical Record |
253 |
0 |
424 |
0 |
1 |
0.5967 |
0 |
N/A |
3 |
N/A |
$1,668,975.00 |
DY11 |
DPH |
Riverside University Health System |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
1908 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,668,975.00 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
35448 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.2 |
Care Coordinator Assignment |
5407 |
0 |
7233 |
0 |
1 |
0.7475 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1603 |
0 |
6435 |
0 |
1 |
0.2491 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
27 |
0 |
716 |
0 |
1 |
0.0377 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.5.f |
Screening for Clinical Depression and follow-up |
13256 |
0 |
34239 |
0 |
1 |
0.3872 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.1.6.t |
Tobacco Assessment and Counseling |
32590 |
0 |
34803 |
0 |
1 |
0.9364 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
35448 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.11 |
REAL data completeness |
0 |
0 |
29802 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.12.f |
Screening for Clinical Depression and follow-up |
13256 |
0 |
34239 |
0 |
1 |
0.3872 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.14.t |
Tobacco Assessment and Counseling |
32590 |
0 |
34803 |
0 |
1 |
0.9364 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.2 |
CG-CAHPS: Provider Rating |
71 |
0 |
100 |
0 |
1 |
0.71 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.3.c |
Colorectal Cancer Screening |
12398 |
0 |
18453 |
0 |
1 |
0.6719 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1603 |
0 |
6435 |
0 |
1 |
0.2491 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.5.b |
Controlling Blood Pressure |
7742 |
0 |
10196 |
0 |
1 |
0.7593 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
1598 |
0 |
1759 |
0 |
1 |
0.9085 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.2.8 |
Prevention Quality Overall Composite #90 |
713 |
0 |
44561 |
0 |
1 |
0.016 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
19983 |
0 |
44210 |
0 |
1 |
0.452 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.2 |
DHCS All-Cause Readmissions |
452 |
0 |
2882 |
0 |
1 |
0.1568 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.3 |
Influenza Immunization |
10780 |
0 |
19867 |
0 |
1 |
0.5426 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.4 |
Post Procedure ED Visits |
446 |
0 |
24441 |
0 |
1 |
0.0182 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
53032 |
0 |
58524 |
0 |
1 |
0.9062 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
11468 |
0 |
58524 |
0 |
1 |
0.196 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.3.7 |
Tobacco Assessment and Counseling |
19188 |
0 |
20366 |
0 |
1 |
0.9422 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.5.1.b |
Controlling Blood Pressure |
7742 |
0 |
10196 |
0 |
1 |
0.7593 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
1598 |
0 |
1759 |
0 |
1 |
0.9085 |
0 |
N/A |
3 |
N/A |
$950,444.45 |
DY11 |
DPH |
San Francisco General Hospital |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
10316 |
0 |
21228 |
0 |
1 |
0.486 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
1.5.4.t |
Tobacco Assessment and Counseling |
32590 |
0 |
34803 |
0 |
1 |
0.9364 |
0 |
N/A |
3 |
N/A |
$950,444.44 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
97 |
0 |
134 |
0 |
1 |
0.7239 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
860 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
81 |
0 |
860 |
0 |
1 |
0.0942 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.5 |
PC-02 Cesarean Section |
52 |
0 |
284 |
0 |
1 |
0.1831 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
390 |
0 |
774 |
0 |
1 |
0.5039 |
0 |
N/A |
3 |
N/A |
$446,295.65 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
581 |
0 |
774 |
0 |
1 |
0.7506 |
0 |
N/A |
3 |
N/A |
$446,295.65 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
24 |
0 |
98 |
0 |
1 |
0.2449 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.8 |
Unexpected Newborn Complications (UNC) |
94 |
0 |
613 |
0 |
1 |
0.1533 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.1.9 |
OB Hemorrhage Safety Bundle |
9 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.2.1 |
DHCS All-Cause Readmissions |
520 |
0 |
3409 |
0 |
1 |
0.1525 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
49 |
0 |
100 |
0 |
1 |
0.49 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.2.3 |
Medication Reconciliation 30 days |
3138 |
0 |
3896 |
0 |
1 |
0.8054 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
4163 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.2.5 |
Timely Transmission of Transition Record |
3223 |
0 |
4145 |
0 |
1 |
0.7776 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.3.1 |
Care Coordinator Assignment |
107 |
0 |
1332 |
0 |
1 |
0.0803 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.3.2 |
Medication Reconciliation 30 days |
697 |
0 |
824 |
0 |
1 |
0.8459 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.3.3 |
Prevention Quality Overall Composite #90 |
162 |
0 |
1332 |
0 |
1 |
0.1216 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.3.4 |
Timely Transmission of Transition Record |
785 |
0 |
919 |
0 |
1 |
0.8542 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
1992 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
710 |
0 |
1692 |
0 |
1 |
0.4196 |
0 |
N/A |
3 |
N/A |
$892,591.31 |
DY11 |
DPH |
San Francisco General Hospital |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
288 |
0 |
1692 |
0 |
1 |
0.1702 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.6.4 |
Screening for Clinical Depression and follow-up |
622 |
0 |
2012 |
0 |
1 |
0.3091 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
1859 |
0 |
2057 |
0 |
1 |
0.9037 |
0 |
N/A |
3 |
N/A |
$892,591.30 |
DY11 |
DPH |
San Francisco General Hospital |
3.3.1 |
Adherence to Medications |
116 |
0 |
160 |
0 |
1 |
0.725 |
0 |
N/A |
3 |
N/A |
$1,710,800.00 |
DY11 |
DPH |
San Francisco General Hospital |
3.3.2 |
Documentation of Current Medications in the Medical Record |
137867 |
0 |
222261 |
0 |
1 |
0.6203 |
0 |
N/A |
3 |
N/A |
$1,710,800.00 |
DY11 |
DPH |
San Francisco General Hospital |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
160 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,710,800.00 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
11165 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.2 |
Care Coordinator Assignment |
0 |
0 |
6482 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
654 |
0 |
2034 |
0 |
1 |
0.3215 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
95 |
0 |
335 |
0 |
1 |
0.2836 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.5.f |
Screening for Clinical Depression and follow-up |
327 |
0 |
411 |
0 |
1 |
0.7956 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.1.6.t |
Tobacco Assessment and Counseling |
7519 |
0 |
9800 |
0 |
1 |
0.7672 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
11165 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.11 |
REAL data completeness |
0 |
0 |
18220 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.12.f |
Screening for Clinical Depression and follow-up |
327 |
0 |
411 |
0 |
1 |
0.7956 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.14.t |
Tobacco Assessment and Counseling |
7519 |
0 |
9800 |
0 |
1 |
0.7672 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.2 |
CG-CAHPS: Provider Rating |
201 |
0 |
273 |
0 |
1 |
0.7363 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.3.c |
Colorectal Cancer Screening |
156 |
0 |
370 |
0 |
1 |
0.4216 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
654 |
0 |
2034 |
0 |
1 |
0.3215 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.5.b |
Controlling Blood Pressure |
255 |
0 |
407 |
0 |
1 |
0.6265 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
581 |
0 |
846 |
0 |
1 |
0.6868 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.2.8 |
Prevention Quality Overall Composite #90 |
188 |
0 |
28942 |
0 |
1 |
0.0065 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
75 |
0 |
377 |
0 |
1 |
0.1989 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.2 |
DHCS All-Cause Readmissions |
38 |
0 |
338 |
0 |
1 |
0.1124 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.3 |
Influenza Immunization |
151 |
0 |
357 |
0 |
1 |
0.423 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.4 |
Post Procedure ED Visits |
85 |
0 |
3015 |
0 |
1 |
0.0282 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
None |
1 |
377 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
491 |
0 |
22169 |
0 |
1 |
0.0221 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.3.7 |
Tobacco Assessment and Counseling |
7381 |
0 |
7989 |
0 |
1 |
0.9239 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.6.1 |
BIRADS to Biopsy |
None |
1 |
44 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.6.2 |
Breast Cancer Screening |
2173 |
0 |
4030 |
0 |
1 |
0.5392 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.6.3 |
Cervical Cancer Screening |
145 |
0 |
411 |
0 |
1 |
0.3528 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.6.4.c |
Colorectal Cancer Screening |
156 |
0 |
370 |
0 |
1 |
0.4216 |
0 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$537,506.25 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
76 |
0 |
108 |
0 |
1 |
0.7037 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
673 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
61 |
0 |
673 |
0 |
1 |
0.0906 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.5 |
PC-02 Cesarean Section |
51 |
0 |
174 |
0 |
1 |
0.2931 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
126 |
0 |
679 |
0 |
1 |
0.1856 |
0 |
N/A |
3 |
N/A |
$250,836.25 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
305 |
0 |
679 |
0 |
1 |
0.4492 |
0 |
N/A |
3 |
N/A |
$250,836.25 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
15 |
0 |
52 |
0 |
1 |
0.2885 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.8 |
Unexpected Newborn Complications (UNC) |
29 |
0 |
482 |
0 |
1 |
0.0602 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.1.9 |
OB Hemorrhage Safety Bundle |
10 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.2.1 |
DHCS All-Cause Readmissions |
107 |
0 |
898 |
0 |
1 |
0.1192 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
5265 |
0 |
10000 |
0 |
1 |
0.5265 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.2.3 |
Medication Reconciliation 30 days |
None |
1 |
341 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
177 |
0 |
191 |
0 |
1 |
0.9267 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
333 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
8779 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.3.2 |
Medication Reconciliation 30 days |
None |
1 |
261 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.3.3 |
Prevention Quality Overall Composite #90 |
139 |
0 |
8773 |
0 |
1 |
0.0158 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
161 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.1 |
Advance Care Plan |
36 |
0 |
323 |
0 |
1 |
0.1115 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
None |
1 |
46 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$501,672.50 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
46 |
0 |
323 |
0 |
1 |
0.1424 |
0 |
N/A |
3 |
N/A |
$752,508.75 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
None |
1 |
84 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$752,508.75 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
2619 |
0 |
2969 |
0 |
1 |
0.8821 |
0 |
N/A |
3 |
N/A |
$752,508.75 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
22 |
0 |
1307 |
0 |
1 |
0.0168 |
0 |
N/A |
3 |
N/A |
$250,836.25 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
98 |
0 |
1307 |
0 |
1 |
0.075 |
0 |
N/A |
3 |
N/A |
$250,836.25 |
DY11 |
DPH |
San Joaquin General Hospital |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
116 |
0 |
1307 |
0 |
1 |
0.0888 |
0 |
N/A |
3 |
N/A |
$250,836.25 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
738 |
0 |
27624 |
0 |
1 |
0.0267 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.2 |
Care Coordinator Assignment |
888 |
0 |
6119 |
0 |
1 |
0.1451 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1333 |
0 |
4937 |
0 |
1 |
0.27 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
None |
4 |
1 |
None |
4 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
579 |
0 |
24302 |
0 |
1 |
0.0238 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
23849 |
0 |
24497 |
0 |
1 |
0.9735 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
738 |
0 |
27624 |
0 |
1 |
0.0267 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.11 |
REAL data completeness |
38504 |
0 |
38656 |
0 |
1 |
0.9961 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
579 |
0 |
24302 |
0 |
1 |
0.0238 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
23849 |
0 |
24497 |
0 |
1 |
0.9735 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
1907 |
0 |
2422 |
0 |
1 |
0.7874 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
5566 |
0 |
9794 |
0 |
1 |
0.5683 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1333 |
0 |
4937 |
0 |
1 |
0.27 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.5.b |
Controlling Blood Pressure |
4782 |
0 |
6767 |
0 |
1 |
0.7067 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
826 |
0 |
985 |
0 |
1 |
0.8386 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
225 |
0 |
38037 |
0 |
1 |
0.0059 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
7524 |
0 |
7524 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
32 |
0 |
434 |
0 |
1 |
0.0737 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.3 |
Influenza Immunization |
7930 |
0 |
13890 |
0 |
1 |
0.5709 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.4 |
Post Procedure ED Visits |
324 |
0 |
9583 |
0 |
1 |
0.0338 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
19 |
0 |
16169 |
0 |
1 |
0.0012 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
16169 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
13561 |
0 |
13785 |
0 |
1 |
0.9838 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.6.1 |
BIRADS to Biopsy |
167 |
0 |
255 |
0 |
1 |
0.6549 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.6.2 |
Breast Cancer Screening |
5252 |
0 |
6630 |
0 |
1 |
0.7922 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.6.3 |
Cervical Cancer Screening |
8321 |
0 |
15213 |
0 |
1 |
0.547 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.6.4.c |
Colorectal Cancer Screening |
5566 |
0 |
9794 |
0 |
1 |
0.5683 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
91 |
0 |
181 |
0 |
1 |
0.5028 |
0 |
N/A |
3 |
N/A |
$560,343.75 |
DY11 |
DPH |
San Mateo Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
32 |
0 |
479 |
0 |
1 |
0.0668 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
5067 |
0 |
10000 |
0 |
1 |
0.5067 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
853 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
965 |
0 |
1044 |
0 |
1 |
0.9243 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
1681 |
0 |
1688 |
0 |
1 |
0.9959 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
445 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
129 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
53 |
0 |
445 |
0 |
1 |
0.1191 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
291 |
0 |
292 |
0 |
1 |
0.9966 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.1 |
Adolescent Well-Care Visit |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.2 |
Developmental Screening in the First Three Years of Life |
None |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.3 |
Documentation of Current Medications in the Medical Record (0-18 yo) |
41 |
0 |
47 |
0 |
1 |
0.8723 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.5 |
Tobacco Assessment and Counseling (13 yo and older) |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.6 |
Well Child Visits - First 15 months of life |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.4.7 |
Well Child Visits - Third, Fourth, Fifth, and Sixth Years of life |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
738 |
0 |
27624 |
0 |
1 |
0.0267 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
21 |
0 |
42 |
0 |
1 |
0.5 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
66 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
145 |
0 |
244 |
0 |
1 |
0.5943 |
0 |
N/A |
3 |
N/A |
$597,700.00 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
217 |
0 |
1610 |
0 |
1 |
0.1348 |
0 |
N/A |
3 |
N/A |
$784,481.25 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
12 |
0 |
154 |
0 |
1 |
0.0779 |
0 |
N/A |
3 |
N/A |
$784,481.25 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
1145 |
0 |
1266 |
0 |
1 |
0.9044 |
0 |
N/A |
3 |
N/A |
$784,481.25 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
72 |
0 |
1745 |
0 |
1 |
0.0413 |
0 |
N/A |
3 |
N/A |
$261,493.75 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
186 |
0 |
1745 |
0 |
1 |
0.1066 |
0 |
N/A |
3 |
N/A |
$261,493.75 |
DY11 |
DPH |
San Mateo Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
233 |
0 |
1745 |
0 |
1 |
0.1335 |
0 |
N/A |
3 |
N/A |
$261,493.75 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
47389 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.2 |
Care Coordinator Assignment |
4308 |
0 |
11573 |
0 |
1 |
0.3722 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2732 |
0 |
7592 |
0 |
1 |
0.3599 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
85 |
0 |
1773 |
0 |
1 |
0.0479 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
10681 |
0 |
32544 |
0 |
1 |
0.3282 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
30645 |
0 |
40262 |
0 |
1 |
0.7611 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
47389 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.11 |
REAL data completeness |
0 |
0 |
43373 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
10681 |
0 |
32544 |
0 |
1 |
0.3282 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
30645 |
0 |
40262 |
0 |
1 |
0.7611 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
2903 |
0 |
3945 |
0 |
1 |
0.7359 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
14926 |
0 |
20061 |
0 |
1 |
0.744 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
2732 |
0 |
7592 |
0 |
1 |
0.3599 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.5.b |
Controlling Blood Pressure |
8440 |
0 |
13371 |
0 |
1 |
0.6312 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
1976 |
0 |
2614 |
0 |
1 |
0.7559 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
503 |
0 |
57281 |
0 |
1 |
0.0088 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
5901 |
0 |
28528 |
0 |
1 |
0.2068 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
548 |
0 |
3677 |
0 |
1 |
0.149 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.3 |
Influenza Immunization |
14527 |
0 |
24406 |
0 |
1 |
0.5952 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.4 |
Post Procedure ED Visits |
568 |
0 |
36646 |
0 |
1 |
0.0155 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
977 |
0 |
47603 |
0 |
1 |
0.0205 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
142 |
0 |
47603 |
0 |
1 |
0.003 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
16677 |
0 |
20811 |
0 |
1 |
0.8014 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
2412 |
0 |
4788 |
0 |
1 |
0.5038 |
0 |
N/A |
3 |
N/A |
$576,362.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
9994 |
0 |
10533 |
0 |
1 |
0.9488 |
0 |
N/A |
3 |
N/A |
$576,362.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
14848 |
0 |
16487 |
0 |
1 |
0.9006 |
0 |
N/A |
3 |
N/A |
$576,362.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
15508 |
0 |
17839 |
0 |
1 |
0.8693 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
723 |
0 |
917 |
0 |
1 |
0.7884 |
0 |
N/A |
3 |
N/A |
$1,729,087.50 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
1066 |
0 |
2117 |
0 |
1 |
0.5035 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
2394 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
80 |
0 |
2394 |
0 |
1 |
0.0334 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.5 |
PC-02 Cesarean Section |
143 |
0 |
711 |
0 |
1 |
0.2011 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
323 |
0 |
505 |
0 |
1 |
0.6396 |
0 |
N/A |
3 |
N/A |
$719,300.40 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
433 |
0 |
505 |
0 |
1 |
0.8574 |
0 |
N/A |
3 |
N/A |
$719,300.40 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
22 |
0 |
243 |
0 |
1 |
0.0905 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
65 |
0 |
1877 |
0 |
1 |
0.0346 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
4 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
584 |
0 |
4161 |
0 |
1 |
0.1404 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
4201 |
0 |
10000 |
0 |
1 |
0.4201 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
2776 |
0 |
4811 |
0 |
1 |
0.577 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
7880 |
0 |
8208 |
0 |
1 |
0.96 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
1611 |
0 |
6094 |
0 |
1 |
0.2644 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.3.1 |
Care Coordinator Assignment |
577 |
0 |
939 |
0 |
1 |
0.6145 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
197 |
0 |
324 |
0 |
1 |
0.608 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
46 |
0 |
939 |
0 |
1 |
0.049 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
103 |
0 |
370 |
0 |
1 |
0.2784 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.1 |
Adolescent Well-Care Visit |
75 |
0 |
83 |
0 |
1 |
0.9036 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.2 |
Developmental Screening in the First Three Years of Life |
0 |
0 |
122 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.3 |
Documentation of Current Medications in the Medical Record (0-18 yo) |
1107 |
0 |
1363 |
0 |
1 |
0.8122 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
66 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.5 |
Tobacco Assessment and Counseling (13 yo and older) |
38 |
0 |
70 |
0 |
1 |
0.5429 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.6 |
Well Child Visits - First 15 months of life |
22 |
0 |
43 |
0 |
1 |
0.5116 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
2.4.7 |
Well Child Visits - Third, Fourth, Fifth, and Sixth Years of life |
92 |
0 |
103 |
0 |
1 |
0.8932 |
0 |
N/A |
3 |
N/A |
$1,438,600.80 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
3.3.1 |
Adherence to Medications |
0 |
0 |
91 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$2,997,085.00 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
3.3.2 |
Documentation of Current Medications in the Medical Record |
292803 |
0 |
357788 |
0 |
1 |
0.8184 |
0 |
N/A |
3 |
N/A |
$2,997,085.00 |
DY11 |
DPH |
Santa Clara Valley Medical Center |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
195 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$2,997,085.00 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
64730 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.2 |
Care Coordinator Assignment |
638 |
0 |
6927 |
0 |
1 |
0.0921 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1486 |
0 |
6927 |
0 |
1 |
0.2145 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
11 |
0 |
789 |
0 |
1 |
0.0139 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
901 |
0 |
50055 |
0 |
1 |
0.018 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
53905 |
0 |
60986 |
0 |
1 |
0.8839 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
64730 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.11 |
REAL data completeness |
69091 |
0 |
74134 |
0 |
1 |
0.932 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
901 |
0 |
50055 |
0 |
1 |
0.018 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
53905 |
0 |
60986 |
0 |
1 |
0.8839 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
3967 |
0 |
4860 |
0 |
1 |
0.8163 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
20437 |
0 |
30013 |
0 |
1 |
0.6809 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1486 |
0 |
6927 |
0 |
1 |
0.2145 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.5.b |
Controlling Blood Pressure |
15599 |
0 |
22546 |
0 |
1 |
0.6919 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
3235 |
0 |
3527 |
0 |
1 |
0.9172 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
474 |
0 |
61767 |
0 |
1 |
0.0077 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
6390 |
0 |
81492 |
0 |
1 |
0.0784 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
666 |
0 |
5834 |
0 |
1 |
0.1142 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.3 |
Influenza Immunization |
23046 |
0 |
44680 |
0 |
1 |
0.5158 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.4 |
Post Procedure ED Visits |
810 |
0 |
91440 |
0 |
1 |
0.0089 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
69650 |
0 |
103486 |
0 |
1 |
0.673 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
416 |
0 |
103642 |
0 |
1 |
0.004 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
40573 |
0 |
44647 |
0 |
1 |
0.9088 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.5.1.b |
Controlling Blood Pressure |
15599 |
0 |
22546 |
0 |
1 |
0.6919 |
0 |
N/A |
3 |
N/A |
$811,572.23 |
DY11 |
DPH |
UC Davis Medical Center |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
3235 |
0 |
3527 |
0 |
1 |
0.9172 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
30982 |
0 |
60986 |
0 |
1 |
0.508 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
1.5.4.t |
Tobacco Assessment and Counseling |
53905 |
0 |
60986 |
0 |
1 |
0.8839 |
0 |
N/A |
3 |
N/A |
$811,572.22 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
208 |
0 |
303 |
0 |
1 |
0.6865 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1473 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
146 |
0 |
1473 |
0 |
1 |
0.0991 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.5 |
PC-02 Cesarean Section |
128 |
0 |
513 |
0 |
1 |
0.2495 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
652 |
0 |
1272 |
0 |
1 |
0.5126 |
0 |
N/A |
3 |
N/A |
$381,086.09 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1089 |
0 |
1272 |
0 |
1 |
0.8561 |
0 |
N/A |
3 |
N/A |
$381,086.09 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
None |
1 |
101 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
60 |
0 |
1037 |
0 |
1 |
0.0579 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
5 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
697 |
0 |
6235 |
0 |
1 |
0.1118 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
3130 |
0 |
5504 |
0 |
1 |
0.5687 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
4952 |
0 |
6578 |
0 |
1 |
0.7528 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
7398 |
0 |
7714 |
0 |
1 |
0.959 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
6323 |
0 |
6593 |
0 |
1 |
0.959 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.3.1 |
Care Coordinator Assignment |
215 |
0 |
979 |
0 |
1 |
0.2196 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
714 |
0 |
928 |
0 |
1 |
0.7694 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
289 |
0 |
978 |
0 |
1 |
0.2955 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
886 |
0 |
928 |
0 |
1 |
0.9547 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
3978 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
261 |
0 |
1917 |
0 |
1 |
0.1362 |
0 |
N/A |
3 |
N/A |
$762,172.18 |
DY11 |
DPH |
UC Davis Medical Center |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
68 |
0 |
357 |
0 |
1 |
0.1905 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.6.4 |
Screening for Clinical Depression and follow-up |
70 |
0 |
2494 |
0 |
1 |
0.0281 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
3483 |
0 |
3993 |
0 |
1 |
0.8723 |
0 |
N/A |
3 |
N/A |
$762,172.17 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
408 |
0 |
2998 |
0 |
1 |
0.1361 |
0 |
N/A |
3 |
N/A |
$1,095,622.50 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
299 |
0 |
309 |
0 |
1 |
0.9676 |
0 |
N/A |
3 |
N/A |
$1,095,622.50 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
1534 |
0 |
1729 |
0 |
1 |
0.8872 |
0 |
N/A |
3 |
N/A |
$1,095,622.50 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
174 |
0 |
7550 |
0 |
1 |
0.023 |
0 |
N/A |
3 |
N/A |
$365,207.50 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
338 |
0 |
7550 |
0 |
1 |
0.0448 |
0 |
N/A |
3 |
N/A |
$365,207.50 |
DY11 |
DPH |
UC Davis Medical Center |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
1540 |
0 |
7550 |
0 |
1 |
0.204 |
0 |
N/A |
3 |
N/A |
$365,207.50 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
1204 |
0 |
13789 |
0 |
1 |
0.0873 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.2 |
Care Coordinator Assignment |
408 |
0 |
4167 |
0 |
1 |
0.0979 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
781 |
0 |
2834 |
0 |
1 |
0.2756 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
1491 |
0 |
11465 |
0 |
1 |
0.13 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
11704 |
0 |
12369 |
0 |
1 |
0.9462 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
1204 |
0 |
13789 |
0 |
1 |
0.0873 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.11 |
REAL data completeness |
0 |
0 |
16856 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
1491 |
0 |
11465 |
0 |
1 |
0.13 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
11704 |
0 |
12369 |
0 |
1 |
0.9462 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
3274 |
0 |
3957 |
0 |
1 |
0.8274 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
2884 |
0 |
5849 |
0 |
1 |
0.4931 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
781 |
0 |
2834 |
0 |
1 |
0.2756 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.5.b |
Controlling Blood Pressure |
2991 |
0 |
4360 |
0 |
1 |
0.686 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
825 |
0 |
1238 |
0 |
1 |
0.6664 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
783 |
0 |
29062 |
0 |
1 |
0.0269 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
6767 |
0 |
8110 |
0 |
1 |
0.8344 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
246 |
0 |
1564 |
0 |
1 |
0.1573 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.3 |
Influenza Immunization |
2889 |
0 |
6646 |
0 |
1 |
0.4347 |
0 |
N/A |
3 |
N/A |
$525,383.66 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.4 |
Post Procedure ED Visits |
1457 |
0 |
26652 |
0 |
1 |
0.0547 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
3203 |
0 |
21934 |
0 |
1 |
0.146 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
53 |
0 |
33119 |
0 |
1 |
0.0016 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
6749 |
0 |
6927 |
0 |
1 |
0.9743 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
261 |
0 |
356 |
0 |
1 |
0.7331 |
0 |
N/A |
3 |
N/A |
$175,127.89 |
DY11 |
DPH |
UC Irvine Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
798 |
0 |
997 |
0 |
1 |
0.8004 |
0 |
N/A |
3 |
N/A |
$175,127.89 |
DY11 |
DPH |
UC Irvine Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
3801 |
0 |
3976 |
0 |
1 |
0.956 |
0 |
N/A |
3 |
N/A |
$175,127.89 |
DY11 |
DPH |
UC Irvine Medical Center |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
1234 |
0 |
1527 |
0 |
1 |
0.8081 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
448 |
0 |
1207 |
0 |
1 |
0.3712 |
0 |
N/A |
3 |
N/A |
$525,383.65 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
150 |
0 |
230 |
0 |
1 |
0.6522 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1333 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
179 |
0 |
1333 |
0 |
1 |
0.1343 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.5 |
PC-02 Cesarean Section |
110 |
0 |
443 |
0 |
1 |
0.2483 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
551 |
0 |
1196 |
0 |
1 |
0.4607 |
0 |
N/A |
3 |
N/A |
$237,564.79 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
785 |
0 |
1196 |
0 |
1 |
0.6564 |
0 |
N/A |
3 |
N/A |
$237,564.79 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
27 |
0 |
135 |
0 |
1 |
0.2 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
33 |
0 |
833 |
0 |
1 |
0.0396 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
8 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
270 |
0 |
1824 |
0 |
1 |
0.148 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
9443 |
0 |
10000 |
0 |
1 |
0.9443 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
1517 |
0 |
1770 |
0 |
1 |
0.8571 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
1881 |
0 |
3068 |
0 |
1 |
0.6131 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
602 |
0 |
634 |
0 |
1 |
0.9495 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.3.1 |
Care Coordinator Assignment |
380 |
0 |
3734 |
0 |
1 |
0.1018 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
1217 |
0 |
1394 |
0 |
1 |
0.873 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
660 |
0 |
21594 |
0 |
1 |
0.0306 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
502 |
0 |
530 |
0 |
1 |
0.9472 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
None |
1 |
80 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
0 |
80 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$475,129.56 |
DY11 |
DPH |
UC Irvine Medical Center |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
0 |
80 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.6.4 |
Screening for Clinical Depression and follow-up |
None |
1 |
48 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
52 |
0 |
55 |
0 |
1 |
0.9455 |
0 |
N/A |
3 |
N/A |
$475,129.57 |
DY11 |
DPH |
UC Irvine Medical Center |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
64 |
0 |
66 |
0 |
1 |
0.9697 |
0 |
N/A |
3 |
N/A |
$546,399.00 |
DY11 |
DPH |
UC Irvine Medical Center |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
26 |
0 |
270 |
0 |
1 |
0.0963 |
0 |
N/A |
3 |
N/A |
$546,399.00 |
DY11 |
DPH |
UC Irvine Medical Center |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
30015 |
0 |
140310 |
0 |
1 |
0.2139 |
0 |
N/A |
3 |
N/A |
$546,399.00 |
DY11 |
DPH |
UC Irvine Medical Center |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
222 |
0 |
793 |
0 |
1 |
0.2799 |
0 |
N/A |
3 |
N/A |
$546,399.00 |
DY11 |
DPH |
UC Irvine Medical Center |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
13340 |
0 |
10000 |
0 |
1 |
1.334 |
0 |
N/A |
3 |
N/A |
$546,399.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
4570 |
0 |
105895 |
0 |
1 |
0.0432 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.2 |
Care Coordinator Assignment |
5029 |
0 |
11958 |
0 |
1 |
0.4206 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1557 |
0 |
8761 |
0 |
1 |
0.1777 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
452 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
12595 |
0 |
80752 |
0 |
1 |
0.156 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
96021 |
0 |
100619 |
0 |
1 |
0.9543 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
4570 |
0 |
105895 |
0 |
1 |
0.0432 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.11 |
REAL data completeness |
109093 |
0 |
119321 |
0 |
1 |
0.9143 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
12591 |
0 |
80752 |
0 |
1 |
0.1559 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
96021 |
0 |
100619 |
0 |
1 |
0.9543 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
238 |
0 |
308 |
0 |
1 |
0.7727 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
22328 |
0 |
43817 |
0 |
1 |
0.5096 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1557 |
0 |
8761 |
0 |
1 |
0.1777 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.5.b |
Controlling Blood Pressure |
15606 |
0 |
22852 |
0 |
1 |
0.6829 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
4902 |
0 |
6198 |
0 |
1 |
0.7909 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
688 |
0 |
101850 |
0 |
1 |
0.0068 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
33367 |
0 |
33885 |
0 |
1 |
0.9847 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
632 |
0 |
3632 |
0 |
1 |
0.174 |
0 |
N/A |
3 |
N/A |
$376,748.07 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.3 |
Influenza Immunization |
16762 |
0 |
33610 |
0 |
1 |
0.4987 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.4 |
Post Procedure ED Visits |
1007 |
0 |
90596 |
0 |
1 |
0.0111 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
42972 |
0 |
339004 |
0 |
1 |
0.1268 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
597 |
0 |
50619 |
0 |
1 |
0.0118 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
41082 |
0 |
42475 |
0 |
1 |
0.9672 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
10265 |
0 |
13197 |
0 |
1 |
0.7778 |
0 |
N/A |
3 |
N/A |
$125,582.69 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
17044 |
0 |
18598 |
0 |
1 |
0.9164 |
0 |
N/A |
3 |
N/A |
$125,582.69 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
29747 |
0 |
32242 |
0 |
1 |
0.9226 |
0 |
N/A |
3 |
N/A |
$125,582.69 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
27905 |
0 |
31500 |
0 |
1 |
0.8859 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
934 |
0 |
1830 |
0 |
1 |
0.5104 |
0 |
N/A |
3 |
N/A |
$376,748.08 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
266 |
0 |
350 |
0 |
1 |
0.76 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
426 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
25 |
0 |
426 |
0 |
1 |
0.0587 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.5 |
PC-02 Cesarean Section |
314 |
0 |
1265 |
0 |
1 |
0.2482 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1405 |
0 |
2069 |
0 |
1 |
0.6791 |
0 |
N/A |
3 |
N/A |
$163,257.50 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
1662 |
0 |
2069 |
0 |
1 |
0.8033 |
0 |
N/A |
3 |
N/A |
$163,257.50 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
47 |
0 |
229 |
0 |
1 |
0.2052 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
69 |
0 |
2048 |
0 |
1 |
0.0337 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
32 |
0 |
32 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
1020 |
0 |
5768 |
0 |
1 |
0.1768 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
6044 |
0 |
10000 |
0 |
1 |
0.6044 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
6311 |
0 |
6311 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
8801 |
0 |
9375 |
0 |
1 |
0.9388 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
9073 |
0 |
9392 |
0 |
1 |
0.966 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.3.1 |
Care Coordinator Assignment |
6665 |
0 |
14081 |
0 |
1 |
0.4733 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
3514 |
0 |
3514 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
549 |
0 |
14081 |
0 |
1 |
0.039 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
4724 |
0 |
4865 |
0 |
1 |
0.971 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.1 |
Advance Care Plan |
1082 |
0 |
2698 |
0 |
1 |
0.401 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
55 |
0 |
98 |
0 |
1 |
0.5612 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
21 |
0 |
None |
4 |
1 |
None |
4 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
60 |
0 |
163 |
0 |
1 |
0.3681 |
0 |
N/A |
3 |
N/A |
$326,515.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
3.3.1 |
Adherence to Medications |
35 |
0 |
73 |
0 |
1 |
0.4795 |
0 |
N/A |
3 |
N/A |
$653,030.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
3.3.2 |
Documentation of Current Medications in the Medical Record |
391671 |
0 |
513831 |
0 |
1 |
0.7623 |
0 |
N/A |
3 |
N/A |
$653,030.00 |
DY11 |
DPH |
UC Los Angeles Medical Center |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
158 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$653,030.00 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
33025 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$486,713.88 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.2 |
Care Coordinator Assignment |
114 |
0 |
5980 |
0 |
1 |
0.0191 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
425 |
0 |
2941 |
0 |
1 |
0.1445 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
149 |
0 |
694 |
0 |
1 |
0.2147 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
9454 |
0 |
23835 |
0 |
1 |
0.3966 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
30997 |
0 |
32482 |
0 |
1 |
0.9543 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
33025 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$486,713.88 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.11 |
REAL data completeness |
1901 |
0 |
33585 |
0 |
1 |
0.0566 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
9454 |
0 |
23835 |
0 |
1 |
0.3966 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
30997 |
0 |
32482 |
0 |
1 |
0.9543 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
8002 |
0 |
9210 |
0 |
1 |
0.8688 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
12832 |
0 |
16353 |
0 |
1 |
0.7847 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
425 |
0 |
2941 |
0 |
1 |
0.1445 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.5.b |
Controlling Blood Pressure |
7962 |
0 |
10970 |
0 |
1 |
0.7258 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
3966 |
0 |
4711 |
0 |
1 |
0.8419 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
1261 |
0 |
35542 |
0 |
1 |
0.0355 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
30983 |
0 |
41148 |
0 |
1 |
0.753 |
0 |
N/A |
3 |
N/A |
$486,713.88 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
454 |
0 |
3060 |
0 |
1 |
0.1484 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.3 |
Influenza Immunization |
14841 |
0 |
20900 |
0 |
1 |
0.7101 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.4 |
Post Procedure ED Visits |
805 |
0 |
27314 |
0 |
1 |
0.0295 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
933 |
0 |
145491 |
0 |
1 |
0.0064 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
306 |
0 |
145491 |
0 |
1 |
0.0021 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
21113 |
0 |
21947 |
0 |
1 |
0.962 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.5.1.b |
Controlling Blood Pressure |
7962 |
0 |
10970 |
0 |
1 |
0.7258 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
3966 |
0 |
4711 |
0 |
1 |
0.8419 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
8431 |
0 |
16757 |
0 |
1 |
0.5031 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
1.5.4.t |
Tobacco Assessment and Counseling |
30997 |
0 |
32482 |
0 |
1 |
0.9543 |
0 |
N/A |
3 |
N/A |
$486,713.89 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
967 |
0 |
1425 |
0 |
1 |
0.6786 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
2039 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
172 |
0 |
2039 |
0 |
1 |
0.0844 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.5 |
PC-02 Cesarean Section |
194 |
0 |
773 |
0 |
1 |
0.251 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
1033 |
0 |
1449 |
0 |
1 |
0.7129 |
0 |
N/A |
3 |
N/A |
$219,021.25 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1382 |
0 |
1449 |
0 |
1 |
0.9538 |
0 |
N/A |
3 |
N/A |
$219,021.25 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
37 |
0 |
193 |
0 |
1 |
0.1917 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
97 |
0 |
1043 |
0 |
1 |
0.093 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
16 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
460 |
0 |
3166 |
0 |
1 |
0.1453 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
6034 |
0 |
10000 |
0 |
1 |
0.6034 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
2076 |
0 |
3358 |
0 |
1 |
0.6182 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
2898 |
0 |
2951 |
0 |
1 |
0.982 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
3041 |
0 |
4230 |
0 |
1 |
0.7189 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.3.1 |
Care Coordinator Assignment |
None |
1 |
133 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
189 |
0 |
264 |
0 |
1 |
0.7159 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
121 |
0 |
359 |
0 |
1 |
0.337 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
176 |
0 |
270 |
0 |
1 |
0.6519 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.1 |
Advance Care Plan |
220 |
0 |
476 |
0 |
1 |
0.4622 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
0 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$438,042.50 |
DY11 |
DPH |
UC San Diego Medical Center |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
141 |
0 |
243 |
0 |
1 |
0.5802 |
0 |
N/A |
3 |
N/A |
$328,531.87 |
DY11 |
DPH |
UC San Diego Medical Center |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
455 |
0 |
4168 |
0 |
1 |
0.1092 |
0 |
N/A |
3 |
N/A |
$328,531.87 |
DY11 |
DPH |
UC San Diego Medical Center |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
36294 |
0 |
204616 |
0 |
1 |
0.1774 |
0 |
N/A |
3 |
N/A |
$328,531.87 |
DY11 |
DPH |
UC San Diego Medical Center |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
359 |
0 |
2850 |
0 |
1 |
0.126 |
0 |
N/A |
3 |
N/A |
$328,531.88 |
DY11 |
DPH |
UC San Diego Medical Center |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
12140 |
0 |
10000 |
0 |
1 |
1.214 |
0 |
N/A |
3 |
N/A |
$328,531.88 |
DY11 |
DPH |
UC San Diego Medical Center |
3.3.1 |
Adherence to Medications |
None |
1 |
55 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$328,531.87 |
DY11 |
DPH |
UC San Diego Medical Center |
3.3.2 |
Documentation of Current Medications in the Medical Record |
99617 |
0 |
125045 |
0 |
1 |
0.7966 |
0 |
N/A |
3 |
N/A |
$328,531.88 |
DY11 |
DPH |
UC San Diego Medical Center |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
1882 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$328,531.88 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
32376 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.2 |
Care Coordinator Assignment |
125 |
0 |
2633 |
0 |
1 |
0.0475 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
455 |
0 |
2633 |
0 |
1 |
0.1728 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
154 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
47 |
0 |
414 |
0 |
1 |
0.1135 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
25454 |
0 |
29091 |
0 |
1 |
0.875 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
32376 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.11 |
REAL data completeness |
0 |
0 |
35818 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
47 |
0 |
414 |
0 |
1 |
0.1135 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
25454 |
0 |
29091 |
0 |
1 |
0.875 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
6884 |
0 |
8574 |
0 |
1 |
0.8029 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
9351 |
0 |
12292 |
0 |
1 |
0.7607 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
455 |
0 |
2633 |
0 |
1 |
0.1728 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.5.b |
Controlling Blood Pressure |
6250 |
0 |
8610 |
0 |
1 |
0.7259 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
1622 |
0 |
1948 |
0 |
1 |
0.8326 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
522 |
0 |
30382 |
0 |
1 |
0.0172 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
9984 |
0 |
11615 |
0 |
1 |
0.8596 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
385 |
0 |
2428 |
0 |
1 |
0.1586 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.3 |
Influenza Immunization |
9661 |
0 |
15068 |
0 |
1 |
0.6412 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.4 |
Post Procedure ED Visits |
225 |
0 |
16368 |
0 |
1 |
0.0137 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
36426 |
0 |
40486 |
0 |
1 |
0.8997 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
1305 |
0 |
40486 |
0 |
1 |
0.0322 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
20150 |
0 |
22469 |
0 |
1 |
0.8968 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.6.1 |
BIRADS to Biopsy |
85 |
0 |
208 |
0 |
1 |
0.4087 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.6.2 |
Breast Cancer Screening |
6087 |
0 |
7551 |
0 |
1 |
0.8061 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.6.3 |
Cervical Cancer Screening |
8906 |
0 |
12203 |
0 |
1 |
0.7298 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.6.4.c |
Colorectal Cancer Screening |
9351 |
0 |
12292 |
0 |
1 |
0.7607 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
23 |
0 |
47 |
0 |
1 |
0.4894 |
0 |
N/A |
3 |
N/A |
$592,237.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
No |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
301 |
0 |
360 |
0 |
1 |
0.8361 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
2257 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
200 |
0 |
2257 |
0 |
1 |
0.0886 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.5 |
PC-02 Cesarean Section |
238 |
0 |
1156 |
0 |
1 |
0.2059 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
1724 |
0 |
2210 |
0 |
1 |
0.7801 |
0 |
N/A |
3 |
N/A |
$276,377.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1746 |
0 |
2210 |
0 |
1 |
0.79 |
0 |
N/A |
3 |
N/A |
$276,377.50 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
51 |
0 |
282 |
0 |
1 |
0.1809 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
130 |
0 |
1763 |
0 |
1 |
0.0737 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
11 |
0 |
16 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
391 |
0 |
2617 |
0 |
1 |
0.1494 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
6169 |
0 |
10000 |
0 |
1 |
0.6169 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
1718 |
0 |
2201 |
0 |
1 |
0.7806 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
5145 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
4763 |
0 |
4862 |
0 |
1 |
0.9796 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.3.1 |
Care Coordinator Assignment |
12 |
0 |
86 |
0 |
1 |
0.1395 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
125 |
0 |
167 |
0 |
1 |
0.7485 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
63 |
0 |
86 |
0 |
1 |
0.7326 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
216 |
0 |
218 |
0 |
1 |
0.9908 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.1 |
Advance Care Plan |
116 |
0 |
341 |
0 |
1 |
0.3402 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
21 |
0 |
32 |
0 |
1 |
0.6563 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
59 |
0 |
72 |
0 |
1 |
0.8194 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
88 |
0 |
602 |
0 |
1 |
0.1462 |
0 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
None |
1 |
None |
4 |
1 |
None |
1 |
N/A |
3 |
N/A |
$552,755.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
3.3.1 |
Adherence to Medications |
16 |
0 |
30 |
0 |
1 |
0.5333 |
0 |
N/A |
3 |
N/A |
$1,105,510.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
3.3.2 |
Documentation of Current Medications in the Medical Record |
56672 |
0 |
79751 |
0 |
1 |
0.7106 |
0 |
N/A |
3 |
N/A |
$1,105,510.00 |
DY11 |
DPH |
UC San Francisco Medical Center |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
191 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,105,510.00 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
16 |
0 |
45095 |
0 |
1 |
0.0004 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.2 |
Care Coordinator Assignment |
1743 |
0 |
7927 |
0 |
1 |
0.2199 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1328 |
0 |
6220 |
0 |
1 |
0.2135 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
None |
1 |
170 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.5.f |
Screening for Clinical Depression and follow-up |
962 |
0 |
29195 |
0 |
1 |
0.033 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.1.6.t |
Tobacco Assessment and Counseling |
21769 |
0 |
37878 |
0 |
1 |
0.5747 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
16 |
0 |
45095 |
0 |
1 |
0.0004 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.11 |
REAL data completeness |
0 |
0 |
60121 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.12.f |
Screening for Clinical Depression and follow-up |
962 |
0 |
29195 |
0 |
1 |
0.033 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.14.t |
Tobacco Assessment and Counseling |
21769 |
0 |
37878 |
0 |
1 |
0.5747 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.2 |
CG-CAHPS: Provider Rating |
5119 |
0 |
6542 |
0 |
1 |
0.7825 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.3.c |
Colorectal Cancer Screening |
4482 |
0 |
14249 |
0 |
1 |
0.3145 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
1328 |
0 |
6220 |
0 |
1 |
0.2135 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.5.b |
Controlling Blood Pressure |
6097 |
0 |
9579 |
0 |
1 |
0.6365 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
756 |
0 |
1315 |
0 |
1 |
0.5749 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.2.8 |
Prevention Quality Overall Composite #90 |
235 |
0 |
68880 |
0 |
1 |
0.0034 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
37302 |
0 |
37302 |
0 |
1 |
1 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.2 |
DHCS All-Cause Readmissions |
198 |
0 |
1414 |
0 |
1 |
0.14 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.3 |
Influenza Immunization |
6644 |
0 |
17615 |
0 |
1 |
0.3772 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.4 |
Post Procedure ED Visits |
413 |
0 |
18688 |
0 |
1 |
0.0221 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
6349 |
0 |
18739 |
0 |
1 |
0.3388 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
0 |
26588 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.3.7 |
Tobacco Assessment and Counseling |
9759 |
0 |
16630 |
0 |
1 |
0.5868 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.5.1.b |
Controlling Blood Pressure |
6097 |
0 |
9579 |
0 |
1 |
0.6365 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
756 |
0 |
1315 |
0 |
1 |
0.5749 |
0 |
N/A |
3 |
N/A |
$1,310,283.34 |
DY11 |
DPH |
Ventura County Medical Center |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
5014 |
0 |
30682 |
0 |
1 |
0.1634 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
1.5.4.t |
Tobacco Assessment and Counseling |
21769 |
0 |
37878 |
0 |
1 |
0.5747 |
0 |
N/A |
3 |
N/A |
$1,310,283.33 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.1 |
Baby Friendly Hospital designation |
Yes |
0 |
BFUSA Cert ? |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
976 |
0 |
1108 |
0 |
1 |
0.8809 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
None |
1 |
1419 |
0 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
59 |
0 |
1419 |
0 |
1 |
0.0416 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.5 |
PC-02 Cesarean Section |
79 |
0 |
374 |
0 |
1 |
0.2112 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
1084 |
0 |
1506 |
0 |
1 |
0.7198 |
0 |
N/A |
3 |
N/A |
$566,042.40 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
1084 |
0 |
1506 |
0 |
1 |
0.7198 |
0 |
N/A |
3 |
N/A |
$566,042.40 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
29 |
0 |
132 |
0 |
1 |
0.2197 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.8 |
Unexpected Newborn Complications (UNC) |
51 |
0 |
1091 |
0 |
1 |
0.0467 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.1.9 |
OB Hemorrhage Safety Bundle |
24 |
0 |
32 |
0 |
1 |
see specification |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.2.1 |
DHCS All-Cause Readmissions |
151 |
0 |
1327 |
0 |
1 |
0.1138 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
5171 |
0 |
10000 |
0 |
1 |
0.5171 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.2.3 |
Medication Reconciliation 30 days |
1265 |
0 |
1944 |
0 |
1 |
0.6507 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
714 |
0 |
4980 |
0 |
1 |
0.1434 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.2.5 |
Timely Transmission of Transition Record |
233 |
0 |
4045 |
0 |
1 |
0.0576 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.3.1 |
Care Coordinator Assignment |
172 |
0 |
560 |
0 |
1 |
0.3071 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.3.2 |
Medication Reconciliation 30 days |
171 |
0 |
254 |
0 |
1 |
0.6732 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.3.3 |
Prevention Quality Overall Composite #90 |
44 |
0 |
680 |
0 |
1 |
0.0647 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.3.4 |
Timely Transmission of Transition Record |
263 |
0 |
480 |
0 |
1 |
0.5479 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.1 |
Adolescent Well-Care Visit |
49 |
0 |
76 |
0 |
1 |
0.6447 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.2 |
Developmental Screening in the First Three Years of Life |
27 |
0 |
53 |
0 |
1 |
0.5094 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.3 |
Documentation of Current Medications in the Medical Record (0-18 yo) |
731 |
0 |
1069 |
0 |
1 |
0.6838 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.4 |
Screening for Clinical Depression and follow-up |
11 |
0 |
50 |
0 |
1 |
0.22 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.5 |
Tobacco Assessment and Counseling (13 yo and older) |
24 |
0 |
43 |
0 |
1 |
0.5581 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.6 |
Well Child Visits - First 15 months of life |
14 |
0 |
43 |
0 |
1 |
0.3256 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
2.4.7 |
Well Child Visits - Third, Fourth, Fifth, and Sixth Years of life |
28 |
0 |
34 |
0 |
1 |
0.8235 |
0 |
N/A |
3 |
N/A |
$1,132,084.80 |
DY11 |
DPH |
Ventura County Medical Center |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
45 |
0 |
111 |
0 |
1 |
0.4054 |
0 |
N/A |
3 |
N/A |
$1,415,106.00 |
DY11 |
DPH |
Ventura County Medical Center |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$1,415,106.00 |
DY11 |
DPH |
Ventura County Medical Center |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
93 |
0 |
110 |
0 |
1 |
0.8455 |
0 |
N/A |
3 |
N/A |
$1,415,106.00 |
DY11 |
DPH |
Ventura County Medical Center |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
14 |
0 |
None |
4 |
1 |
None |
4 |
N/A |
3 |
N/A |
$1,415,106.00 |
DY11 |
DPH |
Ventura County Medical Center |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
0 |
0 |
51 |
0 |
1 |
0 |
0 |
N/A |
3 |
N/A |
$1,415,106.00 |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.1 |
Baby Friendly Hospital designation |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.5 |
PC-02 Cesarean Section |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.8 |
Unexpected Newborn Complications (UNC) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.1.9 |
OB Hemorrhage Safety Bundle |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.2.3 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.2.5 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.1 |
Advance Care Plan |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Antelope Valley Hospital, Lancaster |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct literature review of best practices |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Perform gap analysis of metric protocols based on best practices with list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Interview 20 labor and delivery patients that did not receive prenatal care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Create findings report based on analysis of interview responses for review and distribution |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Identify post-acute care resources for AVH patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct training session for care management staff on care transitions |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct analysis of AVH patients with chronic disease and of emergency department patients that are high utilizers based on influential factors. Review and distribute findings report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct literature review of best practices in palliative care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Identify group of four stakeholders including and distribute best practices report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Perform gap analysis of metric protocols based on best practices with list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct literature review of best practices in antibiotic stewardship |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Identify group of four stakeholders including and distribute best practices report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Perform gap analysis of metric protocols based on best practices with list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Create AVH-specific reporting manual for PRIME metric specifications in high-cost imaging |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Train registered nurse and data analyst in PRIME metric guidelines |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Conduct literature review of best practices in blood product management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.66 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Identify group of four stakeholders including and distribute best practices report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY 11 |
DMPH |
Antelope Valley Hospital, Lancaster |
None |
Perform gap analysis of blood product PRIME metric protocols based on best practices with list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$994,166.67 |
DY11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
None |
Evaluate current EHR ability to capture data necessary for assessment of pain management patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$281,250.00 |
DY 11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
None |
Enhance community outreach with local mental health resources |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$281,250.00 |
DY 11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
None |
Evaluate capacity of current services offered at the Family Health Center to determine ability to service additional pain management patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$281,250.00 |
DY 11 |
DMPH |
Bear Valley Community Hospital, Big Bear Lake |
None |
Develop an internal task force to conduct gap analysis on current and anticipated pain management modalities |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$281,250.00 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
N/A |
3 |
N/A |
$160,714.28 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
N/A |
3 |
N/A |
$160,714.28 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
N/A |
3 |
N/A |
$160,714.28 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.5.1.b |
Controlling Blood Pressure |
16 |
0 |
31 |
0 |
1 |
0.5161 |
0 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
None |
1 |
None |
1 |
1 |
None |
1 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
139 |
0 |
140 |
0 |
1 |
0.9929 |
0 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Coalinga Regional Medical Center, Coalinga |
1.5.4.t |
Tobacco Assessment and Counseling |
12 |
0 |
141 |
0 |
1 |
0.0851 |
0 |
N/A |
3 |
N/A |
$160,714.29 |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Eastern Plumas Health Care, Portol |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Organize and convene a PRIME Advisory Committee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Development of key behavioral health job descriptions |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Streamline tele-psychology and tele-psychiatry program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Prepare for building addition to support program expansion |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Identification of available staff education on behavioral health |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Eastern Plumas Health Care, Portol |
None |
Demonstrate patient engagement in plans of care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.1 |
Baby Friendly Hospital designation |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.5 |
PC-02 Cesarean Section |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.8 |
Unexpected Newborn Complications (UNC) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
2.1.9 |
OB Hemorrhage Safety Bundle |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Camino Hospital, Mountain View |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
El Camino Hospital, Mountain View |
None |
Relationships established and needs identified for target PRIME population towards the integration of behavioral health with primary care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
El Camino Hospital, Mountain View |
None |
Hospital Report developed for OB-Delivery metrics 2.1.2, 2.1.3, 2.1.4 by June 30, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
El Camino Hospital, Mountain View |
None |
Clinical workflow in place for MayView prenatal referral to ECH OB Hospitalist in Mountain View and back to MayView Postnatal care by June 30, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
El Camino Hospital, Mountain View |
None |
Improve IT systems capability to identify the source and path of data to report on the Required PRIME metrics for 3.4 Blood utilization |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
El Camino Hospital, Mountain View |
None |
Adopt best practice guidelines for transfusion into EMR order entry process |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.7.1 |
BMI Screening and Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
374 |
0 |
1494 |
None |
1 |
0.2503 |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
155 |
0 |
257 |
None |
1 |
0.6031 |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
246 |
0 |
487 |
None |
1 |
0.5051 |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
19 |
0 |
1040 |
None |
1 |
0.0183 |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
23 |
0 |
1040 |
None |
1 |
0 |
None |
None |
None |
None |
None |
DY11 |
DMPH |
El Centro Regional Medical Center, El Centro |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
351 |
0 |
1040 |
None |
1 |
0 |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
El Centro Regional Medical Center, El Centro |
None |
Convene a PRIME workgroup and preform a gap analysis for NCQA recognition |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,698,750.00 |
DY 11 |
DMPH |
El Centro Regional Medical Center, El Centro |
None |
Analyze and Identify number of pediatric care needs for PCMH guidelines |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,698,750.00 |
DY 11 |
DMPH |
El Centro Regional Medical Center, El Centro |
None |
Analyze current technological registration for SO/GI and REAL infrastructure |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,698,750.00 |
DY 11 |
DMPH |
El Centro Regional Medical Center, El Centro |
None |
Identify key stakeholders and develop an oversight committee for Population Management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,698,750.00 |
DY11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Develop Charter |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.34 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Specify membership of PRIME workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.34 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Convene workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.34 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Complete workforce gap analysis |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Identify training needs |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Develop staffing strategy |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Assess current Information Technology (IT) data and reporting systems |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Identify data and reporting needs under PRIME |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY 11 |
DMPH |
Hazel Hawkins Memorial Hospital, Hollister |
None |
Develop a plan for IT and data reporting improvements |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$218,333.33 |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.7.1 |
BMI Screening and Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Develop standardized screening tool to identify pts at risk for hypertension |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Work with EHR vendor to develop a bi-directional interface between out-patients EHR (ecw) and hospitals EHR (Med Host) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Develop training, train 5 providers, and complete training assessment |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Convene work group to develop a community outreach team |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Participate in community outreach 4 health fairs per year 7 first aid/health check booths at Windsor Town Green per year 2 First aid/health check booth for the city of Cloverdale per year |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Develop a standardized screening tool for breast cancer |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Develop a standardized screening tool for Cervical Cancer |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY 11 |
DMPH |
Healdsburg District Hospital, Healdsburg |
None |
Develop Standardized screening tool for Colorectal Cancer in EHR |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$211,875.00 |
DY11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
None |
Hire FTE for Quality data coordinating |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
None |
Develop ASP Policies and Procedures |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
Jerold Phelps Community Hospital, Garberville |
None |
Develop ASP program performance tracking and reporting process |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
John C. Fremont Healthcare District, Mariposa |
None |
New EHR selected and installed that has ability to track groups of clients for case management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,125,000.00 |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.2 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.3 |
Influenza Immunization |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.4 |
Post Procedure ED Visits |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.3.7 |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.2.3 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.2.5 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.1 |
Advance Care Plan |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a team to establish team-based care standards |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Select EHR Vendor and Complete PRIME data inquiry |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Decision to use STATiT product (MIDAS+) system to serve as patient registry |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop Plan to achieve PCMH recognition |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a training workgroup to establish structure and plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Conduct a workforce gap analysis to support PRIME project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop staffing plan to support PRIME project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Integrate into workflow patient engagement in self-management behaviors and plans of care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Implementation of evidence based program to teach and reinforce self-management skills |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Determine minimum requirements needed for telehealth platform |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Select Telehealth Platform |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a workgroup to identify multidisciplinary care team member composition |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Collect contact information for Medi-Cal MCOs ,FFS and Medi-Cal MCO delegated medical groups prior authorization centers |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Conduct needs assessment for specialty care services including mental health and substance use disorders |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop a list of community based and state or federal resources for tobacco cessation services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop tools for documentation and patient education about medications |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a workgroup to develop a care plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a workgroup to review and recommend approach. Develop Care Management Tools |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Create Strategic Plan for Transitions of Care Program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop Staffing Plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop and implement retail pharmacy |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene a workgroup to conduct literature review to determine if models for standardized workflows exist |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Convene workgroup to discuss strategies of developing a qualitative assessment of high-risk, high-utilizing patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Conduct literature review to assess multiple disciplinary team approaches to and best practices to optimal pain management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Establish Palliative Care Program Committee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.23 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Develop tools, protocols and training modules for Advance Care Planning (ACP) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY 11 |
DMPH |
Kaweah Delta Health Care District, Visalia |
None |
Train all PC and appropriate CDMC Staff on ACP process and documentation |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$877,222.22 |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Kern Valley Healthcare District, Lake Isabella |
None |
Complete workgroup convening for development of a common dual-track clinical pathway for physical and behavioral health needs |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,125,000.00 |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.1 |
Closing the referral loop: receipt of specialist report (CMS50v3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.2 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.3 |
Influenza Immunization |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.4 |
Post Procedure ED Visits |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.5 |
Request for Specialty Care Expertise Turnaround Time |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.6 |
Specialty Care Touches: Specialty Expertise Requests Managed Via Non-Face to Face Specialty Encounters |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.3.7 |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.7.1 |
BMI Screening and Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
2.2.3 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
2.2.5 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Telemedicine, Neurology Services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.37 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
CIHQ Certification for Acute Stroke Ready Hospital Program obtained |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.37 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Telemedicine Telepsychiatry Contract Completed, including Hospital Privileges for telepsychiatrists |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Tenant Improvements Complete for Oncology and General Surgery Clinics |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Application for Licensing and Certification Survey completed and submitted to CDPH |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Clinic Relocation to New Building for Oncology completed |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Primary Care Group Collaboration Agreement for Participation on PRIME Programs |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Provide overview on PRIME and Specifics on Healthier Food Initiative to Dietary Staff |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Development of Post-Discharge Follow-Up Program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.37 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Develop collaborative agreement with Home Health Agency to Provide In-Home Safety and Nursing Assessment Services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.37 |
DY 11 |
DMPH |
Lompoc Valley Medical Center, Lompoc |
None |
Development of the Family Caregiver Support Network |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$388,636.36 |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Identify most frequent Behavioral Mental Health diagnoses among Mono County residents |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Establish teams for PRIME projects |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Select a behavioral health integration assessment tool |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Select a nationally recognized care model for Integration of Behavioral Health and Primary Care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Conduct a gap analysis of the selected Behavioral Mental Health care model to current organizational care protocols |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Develop/select assessment tools and protocols to use |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Identify potential affiliated parties and initiate discussions to expand behavioral mental health services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Identify most frequent Chronic Non-Malignant Pain diagnoses among Mono County residents |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Conduct an analysis to determine workforce infrastructure needed for projects |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Hire staff and define their roles |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Develop organization-wide strategy for chronic non-malignant pain management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Select a nationally recognized care model for Chronic Non-Malignant Pain Management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Conduct a gap analysis of the selected chronic non-malignant pain care model to current organizational care protocols |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Develop/select standard tools to be used for treatment of chronic non-malignant pain patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY 11 |
DMPH |
Mammoth Hospital, Mammoth Lakes |
None |
Train 3 PCPs and 4 Ortho providers on use of CURES and ICD-10 codes for chronic non-malignant pain patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$116,000.00 |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.1 |
Advance Care Plan |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Marin General Hospital, Greenbrae |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Marin General Hospital, Greenbrae |
None |
Establish CCM Task Force and Identify Community Partners to Engage |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$610,000.00 |
DY 11 |
DMPH |
Marin General Hospital, Greenbrae |
None |
Define and identify target population |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$610,000.00 |
DY 11 |
DMPH |
Marin General Hospital, Greenbrae |
None |
Establish PC Task Force and Identify Community Partners to Engage |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$610,000.00 |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
None |
Develop understanding of PRIME Project Workforce needs |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
None |
Implement PRIME Workforce Strategy |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
Mayers Memorial Hospital District, Fall River Mills |
None |
Conduct software gap analysis for PRIME reporting |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Create & convene PRIME Project implementation committee/workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Complete Analysis of Cancer Screening Tools |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Convene ad hoc clinical workgroup which will review and approve the cancer screening tools and Clinical Decision Support tools recommended by the PRIME workgroup. At a minimum, the ad hoc clinical committee will 1) ensure that the screening tools and CDS meet nationally-recognized PRIME metric requirements, and 2) the tools & CDS will integrate well into the clinical workflow |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Complete Assessment of data systems capabilities and needs |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Complete development of a patient care team model |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY 11 |
DMPH |
Mendocino Coast District Hospital, Fort Bragg |
None |
Conduct workforce and training gap analyses and develop staffing strategy |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$187,500.00 |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Modoc Medical Center, Alturas |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Modoc Medical Center, Alturas |
None |
Enhance capabilities and interoperability of current EMR system |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,125,000.00 |
DY11 |
DMPH |
Northern Inyo Hospital, Bishop |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Northern Inyo Hospital, Bishop |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Northern Inyo Hospital, Bishop |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Northern Inyo Hospital, Bishop |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Northern Inyo Hospital, Bishop |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Northern Inyo Hospital, Bishop |
None |
Establish committee to oversee Antibiotic Stewardship activities |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,485,000.00 |
DY 11 |
DMPH |
Northern Inyo Hospital, Bishop |
None |
Develop Antibiotic Stewardship Program Plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,485,000.00 |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Oak Valley Hospital District, Oakdale |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Complete gap analysis of present process compared to NCQA documentation |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Establish support structure for PCMH transformation activities |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Perform a needs assessment to determine additional staff requirements |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Convene a workgroup to identify REAL data values needed to support PRIME and OVHD patient population |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Establish and evaluate new registration scripts used to obtain REAL data |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Identify gaps in reporting and/or communicating abnormal test results |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Redesign systems for reporting and/or communicating abnormal test results |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY 11 |
DMPH |
Oak Valley Hospital District, Oakdale |
None |
Establish new systems and procedures for reporting and/or communicating abnormal test results |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$333,750.00 |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.2.3 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.2.5 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palo Verde Hospital, Blythe |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Appoint 5 staff to develop care management training modules (3 templates for Mini COG, TUG, and PHQ-9) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.07 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop/assign 5 integrated team members to design E.H.R enhancements (Lightbeam, Nursewise integration), conduct 7 trainings and one month trainings to ensure clinical data and documented templates support quality reporting |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.07 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
E.H.R. champions (Barbod/Christ) on new E.H.R. System: 2 champions will develop training schedules for all staff |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop integrated behavioral health team (3 staff out of 3 departments) to design best practice templates for behavior integration plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop curriculum for behavior health integration plan |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop 3 tools / templates in 3 departments for clinical PRIME Projects in behavior and care management (PHQ-9, Mini COG, TUG) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.07 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Train 3 departments (A-C) in PRIME Projects for bx health and advance care planning and documentation |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.07 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Review and update referral criteria in specialty advance care by January, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Identify and establish specialty integrated health care by January, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Establish specialty behavior health care in ED by January, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Hire 3 qualified personnel in the primary setting for outpatient clinic |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop and plan increase number of appointment visits/encounters by 50% within DY11 in outpatient clinic |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY 11 |
DMPH |
Palo Verde Hospital, Blythe |
None |
Develop implementation integrated strategic plan for new clinical services (health home, wound care, prenatal, bx health, including staffing, space, technology, revenue projections, etc.) by January, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$201,923.08 |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.5.1.b |
Controlling Blood Pressure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.7.1 |
BMI Screening and Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.1 |
Advance Care Plan |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Optimal |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Borderline |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.2.4 |
Use of Imaging Studies for Low Back Pain (anytime) Variation of HEDIS Use of Imaging Studies for Low Back Pain measures: Suboptimal |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.3.1 |
Adherence to Medications |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.3.2 |
Documentation of Current Medications in the Medical Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.3.3 |
High-Cost Pharmaceuticals Ordering Protocols |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Develop a workflow to measure BMI on lower acuity patients during Triage in the Emergency Department |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Convene project team regularly |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Define and identify target population |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Establish Palliative Care program committee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Convene recurring interdisciplinary clinical pathway workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY 11 |
DMPH |
Palomar Medical Center, Escondido (including Pomerado Hospital, Poway) |
None |
Convene recurring interdisciplinary utilization steering workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,525,000.00 |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.6.1 |
BIRADS to Biopsy |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.6.2 |
Breast Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.6.3 |
Cervical Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.6.4.c |
Colorectal Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
None |
Select a Transition of Care Program/model |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,310,000.00 |
DY 11 |
DMPH |
Pioneers Memorial Healthcare District, Brawley |
None |
Establish an Antibiotic Stewardship Program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$2,310,000.00 |
DY11 |
DMPH |
Plumas District Hospital, Quincy |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Plumas District Hospital, Quincy |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Plumas District Hospital, Quincy |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Plumas District Hospital, Quincy |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Plumas District Hospital, Quincy |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Plumas District Hospital, Quincy |
None |
Develop referral sources for chronic pain specialty services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY 11 |
DMPH |
Plumas District Hospital, Quincy |
None |
Develop draft uniform care plan that includes method to track multi-modal referrals and Pain Care Agreement tracking |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.5.1.b |
Controlling Blood Pressure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.6.1 |
BIRADS to Biopsy |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.6.2 |
Breast Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.6.3 |
Cervical Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.6.4.c |
Colorectal Cancer Screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.1 |
Advance Care Plan |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.4.1 |
ePBM-01 Pre-op Anemia Screening, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.4.2 |
ePBM-02 Pre-op Hemoglobin Level, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.4.3 |
ePBM-03 Pre-op Type and Crossmatch, Type and Screen, Selected elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.4.4 |
ePBM-04 Initial Transfusion Threshold |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Salinas Valley Memorial Healthcare System |
3.4.5 |
ePBM-05 Outcome of Patient Blood Management, Selected Elective Surgical Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Perform an analysis on data collection for the Patient Safety in the Ambulatory Setting metrics |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.42 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop a reporting toolkit for Patient Safety in the Ambulatory Setting metric specifications |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Perform an analysis on data collection for Project 1.5 metrics |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.42 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop a reporting toolkit for Project 1.5 metric specifications |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Research best practices for cancer screenings and develop a report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop a project charter for the Project 1.6 PRIME team responsible for leading and implementing clinical protocols |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Perform gap analysis of cancer screening protocols and develop associated action items for clinical protocol improvement |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop a transitional care management team with four roles and outlined responsibilities |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop report of care transitions process based on staff interviews |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Conduct an assessment of community resources working relationship with the SVMHS care transitions team |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Research emergency department utilization of PRIME population with diabetes and develop report of patients based on stratifying factors and location |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.42 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Create a hot spot map of high utilizers |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Research best practices in palliative care and create report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Develop a project charter for PRIME project 2.7 team responsible for updating and implementing new clinical protocols |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Conduct gap analysis of existing palliative care protocols and create list of action items for clinical improvements |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Create a project charter for PRIME project 3.1 team responsible for improving antibiotic stewardship |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Research best practices in antibiotic stewardship and create a report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Perform a gap analysis of existing antibiotic protocols including list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Create a project charter for PRIME project 3.4 team responsible for clinical protocol updates and implementation |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Research best practices in blood product stewardship and create a report |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY 11 |
DMPH |
Salinas Valley Memorial Healthcare System |
None |
Perform gap analysis of existing blood product protocols including list of action items |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$363,571.43 |
DY11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
None |
Complete workforce gap analysis |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
None |
Establish PRIME project workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY 11 |
DMPH |
San Bernardino Mountains Community Hospital, Lake Arrowhead |
None |
Complete Data System analysis |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$375,000.00 |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
1.7.1 |
BMI Screening and Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Assess Staffing Needs for Establishing Weight Management Program for Adults and Healthy Children and Families Program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Assess Staffing Needs Assessment for Establishing a Care Transitions Team |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.66 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Identify Post Discharge Resources |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.66 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Create workgroup to perform needed enhancements in the Cardiopulmonary Department relative to our current EMR |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Develop Policies and Procedures for Selection of Cardiopulmonary Rehabilitation Patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Convene workgroup with clinical staff and IT to determine capabilities of tele-health monitoring |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Identify and establish contract with service provider for a tele-health program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Convene a multidisciplinary workgroup |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.66 |
DY 11 |
DMPH |
San Gorgonio Memorial Hospital, Banning |
None |
Develop ASP Policies and Procedures |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$291,666.67 |
DY11 |
DMPH |
Seneca Healthcare District, Chester |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Seneca Healthcare District, Chester |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Seneca Healthcare District, Chester |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Seneca Healthcare District, Chester |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Seneca Healthcare District, Chester |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Seneca Healthcare District, Chester |
None |
Employ a Full-Time Care Coordinator |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,125,000.00 |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
1.7.1 |
BMI Screening and Follow-up |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.3.1 |
Care Coordinator Assignment |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.3.2 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.3.4 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.1 |
Advance Care Plan |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sierra View District Hospital, Porterville |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Establish Project team |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Establish Population Health Committee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Develop processes for care transitions |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Determine patient membership and engagement in program design |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Select patients to participate in Population Health Committee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Define target populations with Data/Documentation team |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Complete system and data reporting analysis to determine changes necessary to capture baseline reporting and metrics |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Conduct an EMR gap analysis on scheduling patients for follow up |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Develop partnerships with community and provider resources including Hospice |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY 11 |
DMPH |
Sierra View District Hospital, Porterville |
None |
Implement referral process for hospice services |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$705,000.00 |
DY11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
None |
Expand Case Management model to include ED/Community Case Management |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY 11 |
DMPH |
Sonoma Valley Hospital, Sonoma |
None |
Develop standardized workflows for inpatient discharge care that includes the integration of Community Health Coaches |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
2.2.3 |
Medication Reconciliation 30 days |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
2.2.5 |
Timely Transmission of Transition Record |
0 |
0 |
0 |
0 |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
None |
Creation of Steering Committee with applicable partners by June 30, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY 11 |
DMPH |
Sonoma West Medical Center, Sebastopol |
None |
Identify all post-acute facilities of this kind within SWMCs service area by 6/30/16 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Southern Inyo Hospital, Lone Pine |
None |
Purchase Open Vista EHR |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,125,000.00 |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
2.6.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
2.6.2 |
Assessment and Management of Chronic Pain: Patients with chronic pain prescribed an opioid who have an opioid agreement form and an annual urine toxicology screen |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
2.6.3 |
Patients with chronic pain on long term opioid therapy checked in PDMPs |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
2.6.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
2.6.5 |
Treatment of Chronic Non-Malignant Pain with Multi-Modal Therapy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Recruit Advisory Group Members and establish meeting schedule for Million Hearts Initiative |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Educate Advisory members on program policy and intervention of Million Hearts Initiative |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Adopt Million Heart Screening assessments and Algorithms Conduct Workforce Gap Analysis to assess needs to successfully carryout the Million Heart Initiative |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Develop and/or revise Job Descriptions for 1 care coordinator, 1 provider champion, and 1 program manager |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Hire Staff1 care coordinator, 1 provider champion, and 1 program manager by May 30, 2016 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Promote the benefits of Smoke Free environment policy by disbursing education material to two community employers(Nevada County Health Department and Tahoe Truckee Recreational Center) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Increase access to Healthy Choices in TFHD hospital vending machines |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Develop policies and procedures for care coordination referrals specific to the chronic non-malignant pain management project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Recruit and Establish a Chronic Pain Advisory Group |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Establish a baseline timeline to list project plan chronologically and set Chronic Pain Advisory Group meetings |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Key Stakeholders set outcome objectives for for PRIME project 2.6 throughout the duration of the project chronic pain management group |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Complete Strengths Weaknesses Opportunities Treats (SWOT) Analysis to evaluate current capacity to execute prime project 2.6 and help prioritize strategies through group input |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Conduct a Workforce Gap Analysis to assess needs to successfully carryout the chronic non-malignant pain management project (2.6) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.28 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Develop and/or revise job descriptions with core responsibilities, recruit/retain candidates, interview candidates specific to the chronic non-malignant pain management project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Hire staff 1 Program Manager, 1 Care Coordinator, 1 LMFT specific to the chronic non-malignant pain management project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Identify distress screening tool for Depression screens |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Create a depression screening policy to include positive outcome specific to the chronic non-malignant pain management project |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Research and identify model for Chronic Pain programs regarding participatory education and consultation for providers |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Enlist Provider Champion to research Safe Prescribe Practices |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Advisory group will identify and select evidenced based medication agreement that aligns with CMS guidelines |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY 11 |
DMPH |
Tahoe Forest Hospital District, Truckee |
None |
Disperse Safe Prescribe Education materials to ED and Health clinics |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$60,714.29 |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.7.1 |
BMI Screening and Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.7.2 |
Partnership for a Healthier Americas Hospital Health Food Initiative external food service verification |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Nutrition |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Weight Assessment - BMI |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
1.7.3 |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents: Counseling for Physical Activity |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.1 |
Baby Friendly Hospital designation |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.5 |
PC-02 Cesarean Section |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.8 |
Unexpected Newborn Complications (UNC) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.1.9 |
OB Hemorrhage Safety Bundle |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.2.1 |
DHCS All-Cause Readmissions |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.2.2 |
H-CAHPS: Care Transition Metrics (3) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.2.3 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.2.4 |
Reconciled Medication List Received by Discharged Patients |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.2.5 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.3.1 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.3.2 |
Medication Reconciliation 30 days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.3.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.3.4 |
Timely Transmission of Transition Record |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.5.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.5.2 |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.5.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.5.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.5.5 |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.1 |
Advance Care Plan |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
3.1.1 |
Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
3.1.2 |
Avoidance of Antibiotic Treatment with Low Colony Urinary Cultures |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
3.1.3 |
National Healthcare Safety Network (NHSN) Antimicrobial Use Measure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
3.1.4 |
Peri-operative Prophylactic Antibiotics Administered after Surgical Closure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tri-City Medical Center, Oceanside |
3.1.5 |
Reduction in Hospital Acquired Clostridium Difficile Infections |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Develop a PRIME implementation workgroup to consist of representatives from administration, IT and relevant project leaders that will convene a minimum of 4 times per year |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Identify space to provide nutritional counseling to patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Collect and analyze data-specific elements associated with perinatal measures from the EHR |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
All perinatal core measures are tracked and trends shared with staff and all providers on a monthly basis. Patterns that require intervention and quality improvement are addressed during these meetings |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Prepare evidence-based educational material for provider and staff education regarding appropriate labor induction criteria |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Conduct a qualitative assessment of a pilot program using a wireless home monitoring system for high-risk patients |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Identify, select technology to rate patients at high-risk for readmission and analyze performance of remote monitoring solution being utilized for pilot program |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Identify referral management solutions that enables improved decision making for patients and families regarding post-acute care |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Conduct feasibility study of utilizing pharmacy intern to perform medication reconciliation |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Conduct analysis of TCHD acute care utilization and readmissions rate |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Create and convene multi-disciplinary supportive care team that may include hospital staff, community-based hospice, home health care and medical providers |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Develop educational plan and educate direct service providers to the supportive care network and process |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Identify and select technology to provide real-time data reporting and reports generation from Cerner (EHR) for pharmacy and infection control |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Identify members to participate in the Antimicrobial Stewardship Committee (ASC) |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY 11 |
DMPH |
Tri-City Medical Center, Oceanside |
None |
Conduct a review the current best practices and guidelines to identify appropriate antimicrobial stewardship interventions |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$702,000.00 |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Trinity Hospital, Weaverville |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Trinity Hospital, Weaverville |
None |
Convene group including existing staff members CIO (Jake Odom), Director of Finance (Jennifer VanMatre), Manager of Clinics (Hollie Malloy), Director of Clinics (Michael Novak), and new staff member/Patient Care Coordinator (Tracy Miller) who will be identified as the MCHD PRIME TEAM |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY 11 |
DMPH |
Trinity Hospital, Weaverville |
None |
Patient Care Coordinator job development with Human Resources and Manager of Clinics and recruitment of new employee |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$562,500.00 |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.2 |
Care Coordinator Assignment |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.3.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.4 |
Depression Remission at 12 Months (CMS159v4) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.5.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.1.6.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.1.a |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.11 |
REAL data completeness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.12.f |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.14.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.2 |
CG-CAHPS: Provider Rating |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.3.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.4.d |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.5.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.7.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.2.8 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.4.1 |
Abnormal Results Follow-Up: Abnormal INR Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.4.1 |
Abnormal Results Follow-Up: Abnormal Potassium Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.4.1 |
Abnormal Results Follow-Up: Abnormal BIRADS Follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.4.2 |
Annual Monitoring for Patients on Persistent Medications |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.4.3 |
INR Monitoring for Individuals on Warfarin |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.5.1.b |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.5.2.i |
Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.5.3 |
PQRS # 317 Preventative Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.5.4.t |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.6.1 |
BIRADS to Biopsy |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.6.2 |
Breast Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.6.3 |
Cervical Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.6.4.c |
Colorectal Cancer Screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
1.6.5 |
Receipt of appropriate follow-up for abnormal CRC screening |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
2.5.1 |
Alcohol and Drug Misuse (SBIRT) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
2.5.2 |
Controlling Blood Pressure |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
2.5.3 |
Prevention Quality Overall Composite #90 |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
2.5.4 |
Screening for Clinical Depression and follow-up |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Tulare Regional Medical Center, Tulare |
2.5.5 |
Tobacco Assessment and Counseling |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Tulare Regional Medical Center, Tulare |
None |
Implement PHQ screenings as part of the primary care visit |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,147,500.00 |
DY 11 |
DMPH |
Tulare Regional Medical Center, Tulare |
None |
Implement standard of care measures- retinal screenings |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,147,500.00 |
DY 11 |
DMPH |
Tulare Regional Medical Center, Tulare |
None |
Create panel of management/ care coordination roles and responsibilities |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,147,500.00 |
DY 11 |
DMPH |
Tulare Regional Medical Center, Tulare |
None |
Perform manual chart extractions to obtain baseline data |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,147,500.00 |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.1 |
Baby Friendly Hospital designation |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.2 |
Exclusive Breast Milk Feeding (PC-05) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.3 |
OB Hemorrhage: Massive Transfusion |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.4 |
OB Hemorrhage: Total Products Transfused |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.5 |
PC-02 Cesarean Section |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.6 |
Prenatal and Postpartum Care: Postpartum Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.6 |
Prenatal and Postpartum Care: Prenatal Care |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.7 |
Severe Maternal Morbidity (SMM) per 100 women with obstetric hemorrhage |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.8 |
Unexpected Newborn Complications (UNC) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.1.9 |
OB Hemorrhage Safety Bundle |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.1 |
Advance Care Plan |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.2 |
Ambulatory Palliative Care Team Established |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.3 |
MWM #8: Treatment Preferences (documentation) Inpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.4 |
MWM #8: Treatment Preferences (documentation) Outpatient |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.5 |
Palliative Care Service Offered at Time of Diagnosis of Advanced Illness |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
2.7.6 |
Proportion Admitted to Hospice for Less Than 3 Days |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
3.2.1 |
Imaging for Routine Headaches (Choosing Wisely) |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
3.2.2 |
Appropriate Emergency Department Utilization of CT for Pulmonary Embolism |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
3.2.3 |
Use of Imaging Studies for Low Back Pain |
0 |
None |
0 |
None |
None |
None |
None |
None |
None |
None |
None |
DY 11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
None |
Convene a Prenatal Diagnostic Clinic workgroup to discuss implementation of PRIME project and necessary resources |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,910,000.00 |
DY 11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
None |
Establish an Inpatient Palliative Care Program using a multidisciplinary, team-based approach |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,910,000.00 |
DY 11 |
DMPH |
Washington Hospital Healthcare System, Fremont |
None |
Convene Imaging workgroup to discuss implementation of PRIME project and necessary resources |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
$1,910,000.00 |